NIP Lungecancer Bibliografi
1. Diagnosis and first-line treatment of patients with lung cancer in Italian general hospitals. G.I.V.I.O. (Interdisciplinary Group for Cancer Evaluation).
Tumori 75[2], 163-167. 30-4-1989.
2. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group [see comments].
Lancet 352[9124], 257-263. 25-7-1998.
3. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials 133.
Br Med J 1995 311, 899-909. 2001.
4. Addington-Hall, J. and McCarthy, M.
Dying from cancer: results of a national population-based investigation.
Palliat.Med. 9[4], 295-305. 1995.
5. Adebonojo, S. A., Bowser, A. N., Moritz, D. M., and Corcoran, P. C.
Impact of revised stage classification of lung cancer on survival: a military experience.
Chest 115[6], 1507-1513. 1999.
6. al Kattan, K., Cattalani, L., and Goldstraw, P.
Bronchopleural fistula after pneumonectomy with a hand suture technique.
Ann.Thorac.Surg. 58[5], 1433-1436. 1994.
7. Anderson, H., Hopwood, P., Stephens, R. J., Thatcher, N., Cottier, B., Nicholson, M., Milroy, R., Maughan, T. S., Falk, S. J., Bond, M. G., Burt, P. A., Connolly, C. K., McIllmurray, M. B., and Carmichael, J.
Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer--a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung Cancer.
Br.J.Cancer 83[4], 447-453. 2000.
8. Andre, F., Grunenwald, D., Pignon, J. P., Dujon, A., Pujol, J. L., Brichon, P. Y., Brouchet, L., Quoix, E., Westeel, V., and Le Chevalier, T.
Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications.
J.Clin.Oncol. 18[16], 2981-2989. 2000.
9. Arriagada, R., Le Chevalier, T., Borie, F., Riviere, A., Chomy, P., Monnet, I., Tardivon, A., Viader, F., Tarayre, M., and Benhamou, S.
Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission.
J.Natl.Cancer Inst. 87[3], 183-190. 1-2-1995.
10. Asamura H.
What are risk faktors for Arrhythmias after thoracic operations?
J.Thorac.Cardiovasc.Surg. 106[1993], 1104-1110. 1-6-1993.
11. Asamura, H., Naruke, T., Tsuchiya, R., Goya, T., Kondo, H., and Suemasu, K.
Bronchopleural fistulas associated with lung cancer operations. Univariate and multivariate analysis of risk factors, management, and outcome.
J.Thorac.Cardiovasc.Surg. 104[5], 1456-1464. 1992.
12. Ball, D., Matthews, J., Worotniuk, V., and Crennan, E.
Longer survival with higher doses of thoracic radiotherapy in patients with limited non-small cell lung cancer [see comments].
Int.J.Radiat.Oncol.Biol.Phys. 25[4], 599-604. 15-3-1993.
13. Ball, D., Bishop, J., Smith, J., O'Brien, P., Davis, S., Ryan, G., Olver, I., Toner, G., Walker, Q., and Joseph, D.
A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial [see comments].
Radiother.Oncol. 52[2], 129-136. 1999.
14. Bernard, A., Ferrand, L., Hagry, O., Benoit, L., Cheynel, N., and Favre, J. P.
Identification of prognostic factors determining risk groups for lung resection.
Ann.Thorac.Surg. 70[4], 1161-1167. 2000.
15. Berry, D. L., Wilkie, D. J., Huang, H. Y., and Blumenstein, B. A.
Cancer pain and common pain: a comparison of patient-reported intensities.
Oncol.Nurs.Forum 26[4], 721-726. 1999.
16. Billing, J. S. and Wells, F. C.
Delays in the diagnosis and surgical treatment of lung cancer.
Thorax 51[9], 903-906. 1996.
17. Bleehen, N. M., Girling, D. J., Machin, D., and Stephens, R. J.
A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Cancer Working Party.
Br.J.Cancer 68[6], 1150-1156. 1993.
18. Bonomi, P., Kim, K., Fairclough, D., Cella, D., Kugler, J., Rowinsky, E., Jiroutek, M., and Johnson, D.
Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial.
J.Clin.Oncol. 18[3], 623-631. 2000.
19. Bouchardy, C., Fioretta, G., de Perrot, M., Obradovic, M., and Spiliopoulos, A.
Determinants of long term survival after surgery for cancer of the lung: A population-based study.
Cancer 86[11], 2229-2237. 1-12-1999.
20. Breathnach, O. S., Freidlin, B., Conley, B., Green, M. R., Johnson, D. H., Gandara, D. R., O'Connell, M., Shepherd, F. A., and Johnson, B. E.
Twenty-two years of phase iii trials for patients with advanced non-small-cell lung cancer: sobering results.
J.Clin.Oncol. 19[6], 1734-1742. 15-3-2001.
21. Brooks, B. J., Seifter, E. J., Walsh, T. E., Lichter, A. S., Bunn, P. A., Zabell, A., Johnston-Early, A., Edison, M., Makuch, R. W., Cohen, M. H., and .
Pulmonary toxicity with combined modality therapy for limited stage small-cell lung cancer.
J.Clin.Oncol. 4[2], 200-209. 1986.
22. Brundage, M. D., Bezjak, A., Dixon, P., Grimard, L., Larochelle, M., Warde, P., and Warr, D.
The role of palliative thoracic radiotherapy in non-small cell lung cancer.
Can.J.Oncol. 6 Suppl 1, 25-32. 1996.
23. Brundage, M. D. and Mackillop, W. J.
Locally advanced non-small cell lung cancer: do we know the questions? A survey of randomized trials from 1966-1993.
J.Clin.Epidemiol. 49[2], 183-192. 1996.
24. Brunelli, A., Fianchini, A., Gesuita, R., and Carle, F.
POSSUM scoring system as an instrument of audit in lung resection surgery. Physiological and operative severity score for the enumeration of mortality and morbidity.
Ann.Thorac.Surg. 67[2], 329-331. 1999.
25. Buccheri, G. and Ferrigno, D.
Prognostic value of stage grouping and TNM descriptors in lung cancer.
Chest 117[5], 1247-1255. 2000.
26. Bueno, R., Richards, W. G., Swanson, S. J., Jaklitsch, M. T., Lukanich, J. M., Mentzer, S. J., and Sugarbaker, D. J.
Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival.
Ann.Thorac.Surg. 70[6], 1826-1831. 2000.
27. Bulzebruck, H., Krysa, S., Bauer, E., Probst, G., Drings, P., and Vogt-Moykopf, I.
Validation of the TNM classification (4th edn) for lung cancer: first results of a prospective study of 1086 patients with surgical treatment.
Eur.J.Cardiothorac.Surg. 5[7], 356-362. 1991.
28. Bulzebruck, H., Bopp, R., Drings, P., Bauer, E., Krysa, S., Probst, G., van Kaick, G., Muller, K. M., and Vogt-Moykopf, I.
New aspects in the staging of lung cancer. Prospective validation of the International Union Against Cancer TNM classification.
Cancer 70[5], 1102-1110. 1-9-1992.
29. Bunn, P. A., Jr., Vokes, E. E., Langer, C. J., and Schiller, J. H.
An update on North American randomized studies in non-small cell lung cancer.
Semin.Oncol. 25[4 Suppl 9], 2-10. 1998.
30. Bunn, P. A., Jr. and Kelly, K.
New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions.
Clin.Cancer Res. 4[5], 1087-1100. 1998.
31. Burnett, R. J. and Wood, D. E.
The new lung cancer staging system: what does it mean?
Surg.Oncol.Clin.N.Am. 8[2], 231-244. 1999.
32. Busch, E., Verazin, G., Antkowiak, J. G., Driscoll, D., and Takita, H.
Pulmonary complications in patients undergoing thoracotomy for lung carcinoma.
Chest 105[3], 760-766. 1994.
33. Campbell, N. C., Elliott, A. M., Sharp, L., Ritchie, L. D., Cassidy, J., and Little, J.
Rural and urban differences in stage at diagnosis of colorectal and lung cancers.
Br.J.Cancer 84[7], 910-914. 2001.
34. Campobasso, O., Andrion, A., Ribotta, M., and Ronco, G.
The value of the 1981 WHO histological classification in inter-observer reproducibility and changing pattern of lung cancer.
Int.J.Cancer 53[2], 205-208. 21-1-1993.
35. Cardenal, F., Lopez-Cabrerizo, M. P., Anton, A., Alberola, V., Massuti, B., Carrato, A., Barneto, I., Lomas, M., Garcia, M., Lianes, P., Montalar, J., Vadell, C., Gonzalez-Larriba, J. L., Nguyen, B., Artal, A., and Rosell, R.
Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer.
J.Clin.Oncol. 17[1], 12-18. 1999.
36. Cardinale, D., Martinoni, A., Cipolla, C. M., Civelli, M., Lamantia, G., Fiorentini, C., and Mezzetti, M.
Atrial fibrillation after operation for lung cancer: clinical and prognostic significance.
Ann.Thorac.Surg. 68[5], 1827-1831. 1999.
37. Carstensen, J. M., Pershagen, G., and Eklund, G.
Mortality in relation to cigarette and pipe smoking: 16 years' observation of 25,000 Swedish men.
J.Epidemiol.Community Health 41[2], 166-172. 1987.
38. Cerny, T., Blair, V., Anderson, H., Bramwell, V., and Thatcher, N.
Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients.
Int.J.Cancer 39[2], 146-149. 15-2-1987.
39. Charloux, A., Hedelin, G., Dietemann, A., Ifoundza, T., Roeslin, N., Pauli, G., and Quoix, E.
Prognostic value of histology in patients with non-small cell lung cancer.
Lung Cancer 17[1], 123-134. 1997.
40. Chen, M., Jiang, G. L., Fu, X. L., Wang, L. J., Qian, H., Chen, G. Y., Zhao, S., and Liu, T. F.
The impact of overall treatment time on outcomes in radiation therapy for non-small cell lung cancer.
Lung Cancer 28[1], 11-19. 2000.
41. Christensen, E. D., Harvald, T., Jendresen, M., Aggestrup, S., and Petterson, G.
The impact of delayed diagnosis of lung cancer on the stage at the time of operation.
Eur.J.Cardiothorac.Surg. 12[6], 880-884. 1997.
42. Chute, J. P., Venzon, D. J., Hankins, L., Okunieff, P., Frame, J. N., Ihde, D. C., and Johnson, B. E.
Outcome of patients with small-cell lung cancer during 20 years of clinical research at the US National Cancer Institute.
Mayo Clin.Proc. 72[10], 901-912. 1997.
43. Ciriaco, P., Mazzone, P., Canneto, B., and Zannini, P.
Supraventricular arrhythmia following lung resection for non-small cell lung cancer and its treatment with amiodarone.
Eur.J.Cardiothorac.Surg. 18[1], 12-16. 2000.
44. Claessens, M. T., Lynn, J., Zhong, Z., Desbiens, N. A., Phillips, R. S., Wu, A. W., Harrell, F. E., and Connors, A. F.
Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.
J.Am.Geriatr.Soc. 48[5 Suppl], S146-S153. 2000.
45. Cook, R. M., Miller, Y. E., and Bunn, P. A.
Small cell lung cancer: etiology, biology, clinical features, staging, and treatment.
Curr.Probl.Cancer 17[2], 69-141. 1993.
46. Cooley, M. E.
Symptoms in adults with lung cancer. A systematic research review.
J.Pain Symptom.Manage. 19[2], 137-153. 2000.
47. Corizzo, C. C., Baker, M. C., and Henkelmann, G. C.
Assessment of patient satisfaction with pain management in small community inpatient and outpatient settings.
Oncol.Nurs.Forum 27[8], 1279-1286. 2000.
48. Cullen, M. H., Billingham, L. J., Woodroffe, C. M., Chetiyawardana, A. D., Gower, N. H., Joshi, R., Ferry, D. R., Rudd, R. M., Spiro, S. G., Cook, J. E., Trask, C., Bessell, E., Connolly, C. K., Tobias, J., and Souhami, R. L.
Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life.
J.Clin.Oncol. 17[10], 3188-3194. 1999.
49. Damhuis, R. A. and Schutte, P. R.
Resection rates and postoperative mortality in 7,899 patients with lung cancer.
Eur.Respir.J. 9[1], 7-10. 1996.
50. Darby, S., Whitley, E., Doll, R., Key, T., and Silcocks, P.
Diet, smoking and lung cancer: a case-control study of 1000 cases and 1500 controls in South-West England.
Br.J.Cancer 84[5], 728-735. 2001.
51. Dautzenberg, B., Arriagada, R., Chammard, A. B., Jarema, A., Mezzetti, M., Mattson, K., Lagrange, J. L., Le Pechoux, C., Lebeau, B., and Chastang, C.
A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Groupe d'Etude et de Traitement des Cancers Bronchiques [see comments].
Cancer 86[2], 265-273. 15-7-1999.
52. De Conno, F., Caraceni, A., Groff, L., Brunelli, C., Donati, I., Tamburini, M., and Ventafridda, V.
Effect of home care on the place of death of advanced cancer patients.
Eur.J.Cancer 32A[7], 1142-1147. 1996.
53. de Perrot, M., Licker, M., Robert, J., and Spiliopoulos, A.
Incidence, risk factors and management of bronchopleural fistulae after pneumonectomy.
Scand.Cardiovasc.J. 33[3], 171-174. 1999.
54. de Perrot, M., Licker, M., Bouchardy, C., Usel, M., Robert, J., and Spiliopoulos, A.
Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinoma.
J.Thorac.Cardiovasc.Surg. 119[1], 21-26. 2000.
55. Deegan, P. C., Heath, L., Brunskill, J., Kinnear, W. J., Morgan, S. A., and Johnston, I. D.
Reducing waiting times in lung cancer.
J.R.Coll.Physicians Lond 32[4], 339-343. 1998.
56. Deslauriers, J., Ginsberg, R. J., Dubois, P., Beaulieu, M., Goldberg, M., and Piraux, M.
Current operative morbidity associated with elective surgical resection for lung cancer.
Can.J.Surg. 32[5], 335-339. 1989.
57. Deslauriers, J., Ginsberg, R. J., Piantadosi, S., and Fournier, B.
Prospective assessment of 30-day operative morbidity for surgical resections in lung cancer.
Chest 106[6 Suppl], 329S-330S. 1994.
58. Deslauriers, J. and Gregoire, J.
Surgical therapy of early non-small cell lung cancer.
Chest 117[4 Suppl 1], 104S-109S. 2000.
59. Deslauriers, J.
Medical complications of combined surgical and nonsurgical therapy.
Curr.Opin.Oncol. 12[2], 127-131. 2000.
60. Dische, S., Gibson, D., Parmar, M., and Saunders, M. I.
Time course from first symptom to treatment in patients with non-small cell lung cancer referred for radiotherapy: a report by the CHART Steering Committee.
Thorax 51[12], 1262-1265. 1996.
61. Duque, J. L., Ramos, G., Castrodeza, J., Cerezal, J., Castanedo, M., Yuste, M. G., and Heras, F.
Early complications in surgical treatment of lung cancer: a prospective, multicenter study. Grupo Cooperativo de Carcinoma Broncogenico de la Sociedad Espanola de Neumologia y Cirugia Toracica.
Ann.Thorac.Surg. 63[4], 944-950. 1997.
62. Edwards, S. L., Roberts, C., McKean, M. E., Cockburn, J. S., Jeffrey, R. R., and Kerr, K. M.
Preoperative histological classification of primary lung cancer: accuracy of diagnosis and use of the non-small cell category.
J.Clin.Pathol. 53[7], 537-540. 2000.
63. Engeland, A., Bjorge, T., Haldorsen, T., and Tretli, S.
Prognosis of patients with lung cancer diagnosed in Norway, 1954-93.
Cancer Causes Control 9[1], 57-65. 1998.
64. Escalante, C. P., Martin, C. G., Elting, L. S., Cantor, S. B., Harle, T. S., Price, K. J., Kish, S. K., Manzullo, E. F., and Rubenstein, E. B.
Dyspnea in cancer patients. Etiology, resource utilization, and survival-implications in a managed care world.
Cancer 78[6], 1314-1319. 15-9-1996.
65. Evans, W. K., Kocha, W., Gagliardi, A., Eady, A., and Newman, T. E.
The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
Cancer Prev.Control 3[1], 84-94. 1999.
66. Facciolo, F., Cardillo, G., Lopergolo, M., Pallone, G., Sera, F., and Martelli, M.
Chest wall invasion in non-small cell lung carcinoma: A rationale for en bloc resection.
J.Thorac.Cardiovasc.Surg. 121[4 Pt 1], 649-656. 2001.
67. Faggiano, F., Partanen, T., Kogevinas, M., and Boffetta, P.
Socioeconomic differences in cancer incidence and mortality.
IARC Sci.Publ. [138], 65-176. 1997.
68. Feld, R.
Complications associated with the treatment of small cell lung cancer.
Lung Cancer 10 Suppl 1, S307-S317. 1994.
69. Ferguson, M. K. and Karrison, T.
Does pneumonectomy for lung cancer adversely influence long-term survival?
J.Thorac.Cardiovasc.Surg. 119[3], 440-448. 2000.
70. Ferguson, M. K., Wang, J., Hoffman, P. C., Haraf, D. J., Olak, J., Masters, G. A., and Vokes, E. E.
Sex-associated differences in survival of patients undergoing resection for lung cancer.
Ann.Thorac.Surg. 69[1], 245-249. 2000.
71. Fernando HC and Goldstraw P.
The accuracy of clinical evaluative intrathoracic staging in lung cancer as assessed by postsurgical pathology staging.
Cancer 1990 65, 2506-2509. 2001.
72. Friberg, S. and Mattson, S.
On the growth rates of human malignant tumors: implications for medical decision making.
J.Surg.Oncol. 65[4], 284-297. 1997.
73. Frodin, J. E.
Lung cancer.
Acta Oncol. 35 Suppl 7, 46-53. 1996.
74. Frost, M. H., Arvizu, R. D., Jayakumar, S., Schoonover, A., Novotny, P., and Zahasky, K.
A multidisciplinary healthcare delivery model for women with breast cancer: patient satisfaction and physical and psychosocial adjustment.
Oncol.Nurs.Forum 26[10], 1673-1680. 1999.
75. Fujisawa, T., Iizasa, T., Saitoh, Y., Sekine, Y., Motohashi, S., Yasukawa, T., Shibuya, K., Hiroshima, K., and Ohwada, H.
Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas.
J.Clin.Oncol. 17[7], 2086-2091. 1999.
76. Geddes, M., Carli, S., Ercolanelli, M., Forno, G., Capelli, M., and Barchielli, A.
Colorectal, lung, and breast cancer care during the three years following the diagnosis: a population-based study.
Tumori 82[3], 210-214. 1996.
77. Giaccone, G., Dalesio, O., McVie, G. J., Kirkpatrick, A., Postmus, P. E., Burghouts, J. T., Bakker, W., Koolen, M. G., Vendrik, C. P., and Roozendaal, K. J.
Maintenance chemotherapy in small-cell lung cancer: long-term results of a randomized trial. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
J.Clin.Oncol. 11[7], 1230-1240. 1993.
78. Giaccone, G., Manegold, C., Rosell, R., Gatzemeier, U., and Quoix, E.
An update on European randomized studies in non-small cell lung cancer.
Semin.Oncol. 25[4 Suppl 9], 11-17. 1998.
79. Ginsberg, R. J. and Rubinstein, L. V.
Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.
Ann.Thorac.Surg. 60[3], 615-622. 1995.
80. Ginsberg, R. J.
Continuing controversies in staging NSCLC: an analysis of the revised 1997 staging system.
Oncology (Huntingt) 12[1 Suppl 2], 51-54. 1998.
81. Gore, J. M., Brophy, C. J., and Greenstone, M. A.
How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer.
Thorax 55[12], 1000-1006. 2000.
82. Graham, P. H., Gebski, V. J., and Langlands, A. O.
Radical radiotherapy for early nonsmall cell lung cancer.
Int.J.Radiat.Oncol.Biol.Phys. 31[2], 261-266. 15-1-1995.
83. Gregor, A., Thomson, C. S., Brewster, D. H., Stroner, P. L., Davidson, J., Fergusson, R. J., and Milroy, R.
Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study.
Thorax 56[3], 212-217. 2001.
84. Greschuchna, D. and Maassen, W.
The importance of histological classification and tumor staging for prognosis after resection of bronchial carcinoma.
Thorac.Cardiovasc.Surg. 28[2], 115-119. 1980.
85. Gridelli, C.
The ELVIS trial: a phase III study of single-agent vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer. Elderly Lung Cancer Vinorelbine Italian Study.
Oncologist. 6 Suppl 1, 4-7. 2001.
86. Hansen, J. and Olsen, J. H.
Survival of Danish cancer patients 1943-1987. Respiratory system.
APMIS Suppl 33, 77-98. 1993.
87. Hansen, J. B., Jensen, M. K., Nielsen, G., Ostergard, I., Hamburger, H., and Sorensen, H. T.
[The role of social factors in the place of death of cancer patients in the county of Nordjylland].
Ugeskr.Laeger 156[12], 1789-91, 1794. 21-3-1994.
88. Harpole-DH, Jr, Herndon, J. E., Young-WG, Jr, Wolfe, W. G., and Sabiston-DC, Jr.
Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence.
Cancer 76[5], 787-796. 1-9-1995.
89. Harpole, D. H., Herndon, J. E., Young, W. G., Wolfe, W. G., and Sabiston, D. C.
Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence.
Cancer 76[5], 787-796. 1-9-1995.
90. Harpole, D. H., Liptay, M. J., DeCamp, M. M., Mentzer, S. J., Swanson, S. J., and Sugarbaker, D. J.
Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhythmias.
Ann.Thorac.Surg. 61[3], 977-982. 1996.
91. Hellbom, M., Brandberg, Y., Glimelius, B., and Sjoden, P. O.
Individual psychological support for cancer patients: utilisation and patient satisfaction.
Patient.Educ.Couns. 34[3], 247-256. 1998.
92. Herndon, J. E., Fleishman, S., Kornblith, A. B., Kosty, M., Green, M. R., and Holland, J.
Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma?
Cancer 85[2], 333-340. 15-1-1999.
93. Hespanhol, V., Queiroga, H., Magalhaes, A., Santos, A. R., Coelho, M., and Marques, A.
Survival predictors in advanced non-small cell lung cancer.
Lung Cancer 13[3], 253-267. 1995.
94. Hillerdal, G.
[Recommendations by the Swedish lung cancer group. Shorter waiting time is a quality requirement in the management of lung cancer].
Lakartidningen 96[43], 4691. 27-10-1999.
95. Hilsenbeck, S. G., Raub, W. A., Jr., and Sridhar, K. S.
Prognostic factors in lung cancer based on multivariate analysis.
Am.J.Clin.Oncol. 16[4], 301-309. 1993.
96. Hoegler, D.
Radiotherapy for palliation of symptoms in incurable cancer.
Curr.Probl.Cancer 21[3], 129-183. 1997.
97. Hollen, P. J., Gralla, R. J., Cox, C., Eberly, S. W., and Kris, M. G.
A dilemma in analysis: issues in the serial measurement of quality of life in patients with advanced lung cancer.
Lung Cancer 18[2], 119-136. 1997.
98. Humphrey E.W.
National survey af the Pattern of Care for Carcinoma of the lung.
J.Thorax.Cardiovasc.Surg 1990 6, 837-843. 1-6-1990.
99. Huwer, H., Volkmer, I., Wiegand, A., Kalweit, G., and Feindt, P.
Squamous cell carcinoma of the lung: prognostic factors affecting the long-term outcome after surgical resection.
Eur.J.Cardiothorac.Surg. 6[9], 498-502. 1992.
100. Ichinose, Y., Yano, T., Asoh, H., Yokoyama, H., Yoshino, I., and Katsuda, Y.
Prognostic factors obtained by a pathologic examination in completely resected non-small-cell lung cancer. An analysis in each pathologic stage.
J.Thorac.Cardiovasc.Surg. 110[3], 601-605. 1995.
101. Inoue, A., Kunitoh, H., Sekine, I., Sumi, M., Tokuuye, K., and Saijo, N.
Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis.
Int.J.Radiat.Oncol.Biol.Phys. 49[3], 649-655. 1-3-2001.
102. Inoue, K., Sato, M., Fujimura, S., Sakurada, A., Takahashi, S., Usuda, K., Kondo, T., Tanita, T., Handa, M., Saito, Y., and Sagawa, M.
Prognostic assessment of 1310 patients with non-small-cell lung cancer who underwent complete resection from 1980 to 1993.
J.Thorac.Cardiovasc.Surg. 116[3], 407-411. 1998.
103. Ishida, T., Inoue, T., Sugio, K., Inoue, K., Inuzuka, S., Tateishi, M., and Sugimachi, K.
Early squamous lung cancer and longer survival rates.
Respiration 60[6], 359-365. 1993.
104. Janssen-Heijnen, M. L., Gatta, G., Forman, D., Capocaccia, R., and Coebergh, J. W.
Variation in survival of patients with lung cancer in Europe, 1985-1989. EUROCARE Working Group.
Eur.J.Cancer 34[14 Spec No], 2191-2196. 1998.
105. Janssen-Heijnen, M. L., Schipper, R. M., Klinkhamer, P. J., Crommelin, M. A., and Coebergh, J. W.
Improvement and plateau in survival of small-cell lung cancer since 1975: a population-based study.
Ann.Oncol. 9[5], 543-547. 1998.
106. Janssen-Heijnen, M. L. and Coebergh, J. W.
Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe.
Lung Cancer 31[2-3], 123-137. 2001.
107. Jassem, J., Skokowski, J., Dziadziuszko, R., Jassem, E., Szymanowska, A., Rzyman, W., and Roszkiewicz, A.
Results of surgical treatment of non-small cell lung cancer: validation of the new postoperative pathologic TNM classification.
J.Thorac.Cardiovasc.Surg. 119[6], 1141-1146. 2000.
108. Jefferson, M. F., Pendleton, N., Faragher, E. B., Dixon, G. R., Myskow, M. W., and Horan, M. A.
'Tumour volume' as a predictor of survival after resection of non-small-cell lung cancer (NSCLC).
Br.J.Cancer 74[3], 456-459. 1996.
109. Kallan, J.
Effects of sociodemographic variables on adult mortality in the United States: comparisons by sex, age, and cause of death [published erratum appears in Soc Biol 1997 Fall-Winter 44(3-4):294].
Soc.Biol. 44[1-2], 136-147. 1997.
110. Kawahara, M., Fukuoka, M., Saijo, N., Nishiwaki, Y., Ikegami, H., Tamura, T., Shimoyama, M., Suemasu, K., and Furuse, K.
Prognostic factors and prognostic staging system for small cell lung cancer.
Jpn.J.Clin.Oncol. 27[3], 158-165. 1997.
111. Kayser, K., Altiner, M., Dienemann, H., and Gabius, H. J.
Changes during the last decade in clinical parameters of operated lung carcinoma patients of a center for thoracic surgery and the prognostic significance of TNM, morphometric, cytometric, and glycohistochemical properties.
Thorac.Cardiovasc.Surg. 45[4], 196-199. 1997.
Tumori 75[2], 163-167. 30-4-1989.
2. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group [see comments].
Lancet 352[9124], 257-263. 25-7-1998.
3. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials 133.
Br Med J 1995 311, 899-909. 2001.
4. Addington-Hall, J. and McCarthy, M.
Dying from cancer: results of a national population-based investigation.
Palliat.Med. 9[4], 295-305. 1995.
5. Adebonojo, S. A., Bowser, A. N., Moritz, D. M., and Corcoran, P. C.
Impact of revised stage classification of lung cancer on survival: a military experience.
Chest 115[6], 1507-1513. 1999.
6. al Kattan, K., Cattalani, L., and Goldstraw, P.
Bronchopleural fistula after pneumonectomy with a hand suture technique.
Ann.Thorac.Surg. 58[5], 1433-1436. 1994.
7. Anderson, H., Hopwood, P., Stephens, R. J., Thatcher, N., Cottier, B., Nicholson, M., Milroy, R., Maughan, T. S., Falk, S. J., Bond, M. G., Burt, P. A., Connolly, C. K., McIllmurray, M. B., and Carmichael, J.
Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer--a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung Cancer.
Br.J.Cancer 83[4], 447-453. 2000.
8. Andre, F., Grunenwald, D., Pignon, J. P., Dujon, A., Pujol, J. L., Brichon, P. Y., Brouchet, L., Quoix, E., Westeel, V., and Le Chevalier, T.
Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications.
J.Clin.Oncol. 18[16], 2981-2989. 2000.
9. Arriagada, R., Le Chevalier, T., Borie, F., Riviere, A., Chomy, P., Monnet, I., Tardivon, A., Viader, F., Tarayre, M., and Benhamou, S.
Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission.
J.Natl.Cancer Inst. 87[3], 183-190. 1-2-1995.
10. Asamura H.
What are risk faktors for Arrhythmias after thoracic operations?
J.Thorac.Cardiovasc.Surg. 106[1993], 1104-1110. 1-6-1993.
11. Asamura, H., Naruke, T., Tsuchiya, R., Goya, T., Kondo, H., and Suemasu, K.
Bronchopleural fistulas associated with lung cancer operations. Univariate and multivariate analysis of risk factors, management, and outcome.
J.Thorac.Cardiovasc.Surg. 104[5], 1456-1464. 1992.
12. Ball, D., Matthews, J., Worotniuk, V., and Crennan, E.
Longer survival with higher doses of thoracic radiotherapy in patients with limited non-small cell lung cancer [see comments].
Int.J.Radiat.Oncol.Biol.Phys. 25[4], 599-604. 15-3-1993.
13. Ball, D., Bishop, J., Smith, J., O'Brien, P., Davis, S., Ryan, G., Olver, I., Toner, G., Walker, Q., and Joseph, D.
A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial [see comments].
Radiother.Oncol. 52[2], 129-136. 1999.
14. Bernard, A., Ferrand, L., Hagry, O., Benoit, L., Cheynel, N., and Favre, J. P.
Identification of prognostic factors determining risk groups for lung resection.
Ann.Thorac.Surg. 70[4], 1161-1167. 2000.
15. Berry, D. L., Wilkie, D. J., Huang, H. Y., and Blumenstein, B. A.
Cancer pain and common pain: a comparison of patient-reported intensities.
Oncol.Nurs.Forum 26[4], 721-726. 1999.
16. Billing, J. S. and Wells, F. C.
Delays in the diagnosis and surgical treatment of lung cancer.
Thorax 51[9], 903-906. 1996.
17. Bleehen, N. M., Girling, D. J., Machin, D., and Stephens, R. J.
A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Cancer Working Party.
Br.J.Cancer 68[6], 1150-1156. 1993.
18. Bonomi, P., Kim, K., Fairclough, D., Cella, D., Kugler, J., Rowinsky, E., Jiroutek, M., and Johnson, D.
Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial.
J.Clin.Oncol. 18[3], 623-631. 2000.
19. Bouchardy, C., Fioretta, G., de Perrot, M., Obradovic, M., and Spiliopoulos, A.
Determinants of long term survival after surgery for cancer of the lung: A population-based study.
Cancer 86[11], 2229-2237. 1-12-1999.
20. Breathnach, O. S., Freidlin, B., Conley, B., Green, M. R., Johnson, D. H., Gandara, D. R., O'Connell, M., Shepherd, F. A., and Johnson, B. E.
Twenty-two years of phase iii trials for patients with advanced non-small-cell lung cancer: sobering results.
J.Clin.Oncol. 19[6], 1734-1742. 15-3-2001.
21. Brooks, B. J., Seifter, E. J., Walsh, T. E., Lichter, A. S., Bunn, P. A., Zabell, A., Johnston-Early, A., Edison, M., Makuch, R. W., Cohen, M. H., and .
Pulmonary toxicity with combined modality therapy for limited stage small-cell lung cancer.
J.Clin.Oncol. 4[2], 200-209. 1986.
22. Brundage, M. D., Bezjak, A., Dixon, P., Grimard, L., Larochelle, M., Warde, P., and Warr, D.
The role of palliative thoracic radiotherapy in non-small cell lung cancer.
Can.J.Oncol. 6 Suppl 1, 25-32. 1996.
23. Brundage, M. D. and Mackillop, W. J.
Locally advanced non-small cell lung cancer: do we know the questions? A survey of randomized trials from 1966-1993.
J.Clin.Epidemiol. 49[2], 183-192. 1996.
24. Brunelli, A., Fianchini, A., Gesuita, R., and Carle, F.
POSSUM scoring system as an instrument of audit in lung resection surgery. Physiological and operative severity score for the enumeration of mortality and morbidity.
Ann.Thorac.Surg. 67[2], 329-331. 1999.
25. Buccheri, G. and Ferrigno, D.
Prognostic value of stage grouping and TNM descriptors in lung cancer.
Chest 117[5], 1247-1255. 2000.
26. Bueno, R., Richards, W. G., Swanson, S. J., Jaklitsch, M. T., Lukanich, J. M., Mentzer, S. J., and Sugarbaker, D. J.
Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival.
Ann.Thorac.Surg. 70[6], 1826-1831. 2000.
27. Bulzebruck, H., Krysa, S., Bauer, E., Probst, G., Drings, P., and Vogt-Moykopf, I.
Validation of the TNM classification (4th edn) for lung cancer: first results of a prospective study of 1086 patients with surgical treatment.
Eur.J.Cardiothorac.Surg. 5[7], 356-362. 1991.
28. Bulzebruck, H., Bopp, R., Drings, P., Bauer, E., Krysa, S., Probst, G., van Kaick, G., Muller, K. M., and Vogt-Moykopf, I.
New aspects in the staging of lung cancer. Prospective validation of the International Union Against Cancer TNM classification.
Cancer 70[5], 1102-1110. 1-9-1992.
29. Bunn, P. A., Jr., Vokes, E. E., Langer, C. J., and Schiller, J. H.
An update on North American randomized studies in non-small cell lung cancer.
Semin.Oncol. 25[4 Suppl 9], 2-10. 1998.
30. Bunn, P. A., Jr. and Kelly, K.
New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions.
Clin.Cancer Res. 4[5], 1087-1100. 1998.
31. Burnett, R. J. and Wood, D. E.
The new lung cancer staging system: what does it mean?
Surg.Oncol.Clin.N.Am. 8[2], 231-244. 1999.
32. Busch, E., Verazin, G., Antkowiak, J. G., Driscoll, D., and Takita, H.
Pulmonary complications in patients undergoing thoracotomy for lung carcinoma.
Chest 105[3], 760-766. 1994.
33. Campbell, N. C., Elliott, A. M., Sharp, L., Ritchie, L. D., Cassidy, J., and Little, J.
Rural and urban differences in stage at diagnosis of colorectal and lung cancers.
Br.J.Cancer 84[7], 910-914. 2001.
34. Campobasso, O., Andrion, A., Ribotta, M., and Ronco, G.
The value of the 1981 WHO histological classification in inter-observer reproducibility and changing pattern of lung cancer.
Int.J.Cancer 53[2], 205-208. 21-1-1993.
35. Cardenal, F., Lopez-Cabrerizo, M. P., Anton, A., Alberola, V., Massuti, B., Carrato, A., Barneto, I., Lomas, M., Garcia, M., Lianes, P., Montalar, J., Vadell, C., Gonzalez-Larriba, J. L., Nguyen, B., Artal, A., and Rosell, R.
Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer.
J.Clin.Oncol. 17[1], 12-18. 1999.
36. Cardinale, D., Martinoni, A., Cipolla, C. M., Civelli, M., Lamantia, G., Fiorentini, C., and Mezzetti, M.
Atrial fibrillation after operation for lung cancer: clinical and prognostic significance.
Ann.Thorac.Surg. 68[5], 1827-1831. 1999.
37. Carstensen, J. M., Pershagen, G., and Eklund, G.
Mortality in relation to cigarette and pipe smoking: 16 years' observation of 25,000 Swedish men.
J.Epidemiol.Community Health 41[2], 166-172. 1987.
38. Cerny, T., Blair, V., Anderson, H., Bramwell, V., and Thatcher, N.
Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients.
Int.J.Cancer 39[2], 146-149. 15-2-1987.
39. Charloux, A., Hedelin, G., Dietemann, A., Ifoundza, T., Roeslin, N., Pauli, G., and Quoix, E.
Prognostic value of histology in patients with non-small cell lung cancer.
Lung Cancer 17[1], 123-134. 1997.
40. Chen, M., Jiang, G. L., Fu, X. L., Wang, L. J., Qian, H., Chen, G. Y., Zhao, S., and Liu, T. F.
The impact of overall treatment time on outcomes in radiation therapy for non-small cell lung cancer.
Lung Cancer 28[1], 11-19. 2000.
41. Christensen, E. D., Harvald, T., Jendresen, M., Aggestrup, S., and Petterson, G.
The impact of delayed diagnosis of lung cancer on the stage at the time of operation.
Eur.J.Cardiothorac.Surg. 12[6], 880-884. 1997.
42. Chute, J. P., Venzon, D. J., Hankins, L., Okunieff, P., Frame, J. N., Ihde, D. C., and Johnson, B. E.
Outcome of patients with small-cell lung cancer during 20 years of clinical research at the US National Cancer Institute.
Mayo Clin.Proc. 72[10], 901-912. 1997.
43. Ciriaco, P., Mazzone, P., Canneto, B., and Zannini, P.
Supraventricular arrhythmia following lung resection for non-small cell lung cancer and its treatment with amiodarone.
Eur.J.Cardiothorac.Surg. 18[1], 12-16. 2000.
44. Claessens, M. T., Lynn, J., Zhong, Z., Desbiens, N. A., Phillips, R. S., Wu, A. W., Harrell, F. E., and Connors, A. F.
Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.
J.Am.Geriatr.Soc. 48[5 Suppl], S146-S153. 2000.
45. Cook, R. M., Miller, Y. E., and Bunn, P. A.
Small cell lung cancer: etiology, biology, clinical features, staging, and treatment.
Curr.Probl.Cancer 17[2], 69-141. 1993.
46. Cooley, M. E.
Symptoms in adults with lung cancer. A systematic research review.
J.Pain Symptom.Manage. 19[2], 137-153. 2000.
47. Corizzo, C. C., Baker, M. C., and Henkelmann, G. C.
Assessment of patient satisfaction with pain management in small community inpatient and outpatient settings.
Oncol.Nurs.Forum 27[8], 1279-1286. 2000.
48. Cullen, M. H., Billingham, L. J., Woodroffe, C. M., Chetiyawardana, A. D., Gower, N. H., Joshi, R., Ferry, D. R., Rudd, R. M., Spiro, S. G., Cook, J. E., Trask, C., Bessell, E., Connolly, C. K., Tobias, J., and Souhami, R. L.
Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life.
J.Clin.Oncol. 17[10], 3188-3194. 1999.
49. Damhuis, R. A. and Schutte, P. R.
Resection rates and postoperative mortality in 7,899 patients with lung cancer.
Eur.Respir.J. 9[1], 7-10. 1996.
50. Darby, S., Whitley, E., Doll, R., Key, T., and Silcocks, P.
Diet, smoking and lung cancer: a case-control study of 1000 cases and 1500 controls in South-West England.
Br.J.Cancer 84[5], 728-735. 2001.
51. Dautzenberg, B., Arriagada, R., Chammard, A. B., Jarema, A., Mezzetti, M., Mattson, K., Lagrange, J. L., Le Pechoux, C., Lebeau, B., and Chastang, C.
A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Groupe d'Etude et de Traitement des Cancers Bronchiques [see comments].
Cancer 86[2], 265-273. 15-7-1999.
52. De Conno, F., Caraceni, A., Groff, L., Brunelli, C., Donati, I., Tamburini, M., and Ventafridda, V.
Effect of home care on the place of death of advanced cancer patients.
Eur.J.Cancer 32A[7], 1142-1147. 1996.
53. de Perrot, M., Licker, M., Robert, J., and Spiliopoulos, A.
Incidence, risk factors and management of bronchopleural fistulae after pneumonectomy.
Scand.Cardiovasc.J. 33[3], 171-174. 1999.
54. de Perrot, M., Licker, M., Bouchardy, C., Usel, M., Robert, J., and Spiliopoulos, A.
Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinoma.
J.Thorac.Cardiovasc.Surg. 119[1], 21-26. 2000.
55. Deegan, P. C., Heath, L., Brunskill, J., Kinnear, W. J., Morgan, S. A., and Johnston, I. D.
Reducing waiting times in lung cancer.
J.R.Coll.Physicians Lond 32[4], 339-343. 1998.
56. Deslauriers, J., Ginsberg, R. J., Dubois, P., Beaulieu, M., Goldberg, M., and Piraux, M.
Current operative morbidity associated with elective surgical resection for lung cancer.
Can.J.Surg. 32[5], 335-339. 1989.
57. Deslauriers, J., Ginsberg, R. J., Piantadosi, S., and Fournier, B.
Prospective assessment of 30-day operative morbidity for surgical resections in lung cancer.
Chest 106[6 Suppl], 329S-330S. 1994.
58. Deslauriers, J. and Gregoire, J.
Surgical therapy of early non-small cell lung cancer.
Chest 117[4 Suppl 1], 104S-109S. 2000.
59. Deslauriers, J.
Medical complications of combined surgical and nonsurgical therapy.
Curr.Opin.Oncol. 12[2], 127-131. 2000.
60. Dische, S., Gibson, D., Parmar, M., and Saunders, M. I.
Time course from first symptom to treatment in patients with non-small cell lung cancer referred for radiotherapy: a report by the CHART Steering Committee.
Thorax 51[12], 1262-1265. 1996.
61. Duque, J. L., Ramos, G., Castrodeza, J., Cerezal, J., Castanedo, M., Yuste, M. G., and Heras, F.
Early complications in surgical treatment of lung cancer: a prospective, multicenter study. Grupo Cooperativo de Carcinoma Broncogenico de la Sociedad Espanola de Neumologia y Cirugia Toracica.
Ann.Thorac.Surg. 63[4], 944-950. 1997.
62. Edwards, S. L., Roberts, C., McKean, M. E., Cockburn, J. S., Jeffrey, R. R., and Kerr, K. M.
Preoperative histological classification of primary lung cancer: accuracy of diagnosis and use of the non-small cell category.
J.Clin.Pathol. 53[7], 537-540. 2000.
63. Engeland, A., Bjorge, T., Haldorsen, T., and Tretli, S.
Prognosis of patients with lung cancer diagnosed in Norway, 1954-93.
Cancer Causes Control 9[1], 57-65. 1998.
64. Escalante, C. P., Martin, C. G., Elting, L. S., Cantor, S. B., Harle, T. S., Price, K. J., Kish, S. K., Manzullo, E. F., and Rubenstein, E. B.
Dyspnea in cancer patients. Etiology, resource utilization, and survival-implications in a managed care world.
Cancer 78[6], 1314-1319. 15-9-1996.
65. Evans, W. K., Kocha, W., Gagliardi, A., Eady, A., and Newman, T. E.
The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
Cancer Prev.Control 3[1], 84-94. 1999.
66. Facciolo, F., Cardillo, G., Lopergolo, M., Pallone, G., Sera, F., and Martelli, M.
Chest wall invasion in non-small cell lung carcinoma: A rationale for en bloc resection.
J.Thorac.Cardiovasc.Surg. 121[4 Pt 1], 649-656. 2001.
67. Faggiano, F., Partanen, T., Kogevinas, M., and Boffetta, P.
Socioeconomic differences in cancer incidence and mortality.
IARC Sci.Publ. [138], 65-176. 1997.
68. Feld, R.
Complications associated with the treatment of small cell lung cancer.
Lung Cancer 10 Suppl 1, S307-S317. 1994.
69. Ferguson, M. K. and Karrison, T.
Does pneumonectomy for lung cancer adversely influence long-term survival?
J.Thorac.Cardiovasc.Surg. 119[3], 440-448. 2000.
70. Ferguson, M. K., Wang, J., Hoffman, P. C., Haraf, D. J., Olak, J., Masters, G. A., and Vokes, E. E.
Sex-associated differences in survival of patients undergoing resection for lung cancer.
Ann.Thorac.Surg. 69[1], 245-249. 2000.
71. Fernando HC and Goldstraw P.
The accuracy of clinical evaluative intrathoracic staging in lung cancer as assessed by postsurgical pathology staging.
Cancer 1990 65, 2506-2509. 2001.
72. Friberg, S. and Mattson, S.
On the growth rates of human malignant tumors: implications for medical decision making.
J.Surg.Oncol. 65[4], 284-297. 1997.
73. Frodin, J. E.
Lung cancer.
Acta Oncol. 35 Suppl 7, 46-53. 1996.
74. Frost, M. H., Arvizu, R. D., Jayakumar, S., Schoonover, A., Novotny, P., and Zahasky, K.
A multidisciplinary healthcare delivery model for women with breast cancer: patient satisfaction and physical and psychosocial adjustment.
Oncol.Nurs.Forum 26[10], 1673-1680. 1999.
75. Fujisawa, T., Iizasa, T., Saitoh, Y., Sekine, Y., Motohashi, S., Yasukawa, T., Shibuya, K., Hiroshima, K., and Ohwada, H.
Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas.
J.Clin.Oncol. 17[7], 2086-2091. 1999.
76. Geddes, M., Carli, S., Ercolanelli, M., Forno, G., Capelli, M., and Barchielli, A.
Colorectal, lung, and breast cancer care during the three years following the diagnosis: a population-based study.
Tumori 82[3], 210-214. 1996.
77. Giaccone, G., Dalesio, O., McVie, G. J., Kirkpatrick, A., Postmus, P. E., Burghouts, J. T., Bakker, W., Koolen, M. G., Vendrik, C. P., and Roozendaal, K. J.
Maintenance chemotherapy in small-cell lung cancer: long-term results of a randomized trial. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
J.Clin.Oncol. 11[7], 1230-1240. 1993.
78. Giaccone, G., Manegold, C., Rosell, R., Gatzemeier, U., and Quoix, E.
An update on European randomized studies in non-small cell lung cancer.
Semin.Oncol. 25[4 Suppl 9], 11-17. 1998.
79. Ginsberg, R. J. and Rubinstein, L. V.
Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.
Ann.Thorac.Surg. 60[3], 615-622. 1995.
80. Ginsberg, R. J.
Continuing controversies in staging NSCLC: an analysis of the revised 1997 staging system.
Oncology (Huntingt) 12[1 Suppl 2], 51-54. 1998.
81. Gore, J. M., Brophy, C. J., and Greenstone, M. A.
How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer.
Thorax 55[12], 1000-1006. 2000.
82. Graham, P. H., Gebski, V. J., and Langlands, A. O.
Radical radiotherapy for early nonsmall cell lung cancer.
Int.J.Radiat.Oncol.Biol.Phys. 31[2], 261-266. 15-1-1995.
83. Gregor, A., Thomson, C. S., Brewster, D. H., Stroner, P. L., Davidson, J., Fergusson, R. J., and Milroy, R.
Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study.
Thorax 56[3], 212-217. 2001.
84. Greschuchna, D. and Maassen, W.
The importance of histological classification and tumor staging for prognosis after resection of bronchial carcinoma.
Thorac.Cardiovasc.Surg. 28[2], 115-119. 1980.
85. Gridelli, C.
The ELVIS trial: a phase III study of single-agent vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer. Elderly Lung Cancer Vinorelbine Italian Study.
Oncologist. 6 Suppl 1, 4-7. 2001.
86. Hansen, J. and Olsen, J. H.
Survival of Danish cancer patients 1943-1987. Respiratory system.
APMIS Suppl 33, 77-98. 1993.
87. Hansen, J. B., Jensen, M. K., Nielsen, G., Ostergard, I., Hamburger, H., and Sorensen, H. T.
[The role of social factors in the place of death of cancer patients in the county of Nordjylland].
Ugeskr.Laeger 156[12], 1789-91, 1794. 21-3-1994.
88. Harpole-DH, Jr, Herndon, J. E., Young-WG, Jr, Wolfe, W. G., and Sabiston-DC, Jr.
Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence.
Cancer 76[5], 787-796. 1-9-1995.
89. Harpole, D. H., Herndon, J. E., Young, W. G., Wolfe, W. G., and Sabiston, D. C.
Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence.
Cancer 76[5], 787-796. 1-9-1995.
90. Harpole, D. H., Liptay, M. J., DeCamp, M. M., Mentzer, S. J., Swanson, S. J., and Sugarbaker, D. J.
Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhythmias.
Ann.Thorac.Surg. 61[3], 977-982. 1996.
91. Hellbom, M., Brandberg, Y., Glimelius, B., and Sjoden, P. O.
Individual psychological support for cancer patients: utilisation and patient satisfaction.
Patient.Educ.Couns. 34[3], 247-256. 1998.
92. Herndon, J. E., Fleishman, S., Kornblith, A. B., Kosty, M., Green, M. R., and Holland, J.
Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma?
Cancer 85[2], 333-340. 15-1-1999.
93. Hespanhol, V., Queiroga, H., Magalhaes, A., Santos, A. R., Coelho, M., and Marques, A.
Survival predictors in advanced non-small cell lung cancer.
Lung Cancer 13[3], 253-267. 1995.
94. Hillerdal, G.
[Recommendations by the Swedish lung cancer group. Shorter waiting time is a quality requirement in the management of lung cancer].
Lakartidningen 96[43], 4691. 27-10-1999.
95. Hilsenbeck, S. G., Raub, W. A., Jr., and Sridhar, K. S.
Prognostic factors in lung cancer based on multivariate analysis.
Am.J.Clin.Oncol. 16[4], 301-309. 1993.
96. Hoegler, D.
Radiotherapy for palliation of symptoms in incurable cancer.
Curr.Probl.Cancer 21[3], 129-183. 1997.
97. Hollen, P. J., Gralla, R. J., Cox, C., Eberly, S. W., and Kris, M. G.
A dilemma in analysis: issues in the serial measurement of quality of life in patients with advanced lung cancer.
Lung Cancer 18[2], 119-136. 1997.
98. Humphrey E.W.
National survey af the Pattern of Care for Carcinoma of the lung.
J.Thorax.Cardiovasc.Surg 1990 6, 837-843. 1-6-1990.
99. Huwer, H., Volkmer, I., Wiegand, A., Kalweit, G., and Feindt, P.
Squamous cell carcinoma of the lung: prognostic factors affecting the long-term outcome after surgical resection.
Eur.J.Cardiothorac.Surg. 6[9], 498-502. 1992.
100. Ichinose, Y., Yano, T., Asoh, H., Yokoyama, H., Yoshino, I., and Katsuda, Y.
Prognostic factors obtained by a pathologic examination in completely resected non-small-cell lung cancer. An analysis in each pathologic stage.
J.Thorac.Cardiovasc.Surg. 110[3], 601-605. 1995.
101. Inoue, A., Kunitoh, H., Sekine, I., Sumi, M., Tokuuye, K., and Saijo, N.
Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis.
Int.J.Radiat.Oncol.Biol.Phys. 49[3], 649-655. 1-3-2001.
102. Inoue, K., Sato, M., Fujimura, S., Sakurada, A., Takahashi, S., Usuda, K., Kondo, T., Tanita, T., Handa, M., Saito, Y., and Sagawa, M.
Prognostic assessment of 1310 patients with non-small-cell lung cancer who underwent complete resection from 1980 to 1993.
J.Thorac.Cardiovasc.Surg. 116[3], 407-411. 1998.
103. Ishida, T., Inoue, T., Sugio, K., Inoue, K., Inuzuka, S., Tateishi, M., and Sugimachi, K.
Early squamous lung cancer and longer survival rates.
Respiration 60[6], 359-365. 1993.
104. Janssen-Heijnen, M. L., Gatta, G., Forman, D., Capocaccia, R., and Coebergh, J. W.
Variation in survival of patients with lung cancer in Europe, 1985-1989. EUROCARE Working Group.
Eur.J.Cancer 34[14 Spec No], 2191-2196. 1998.
105. Janssen-Heijnen, M. L., Schipper, R. M., Klinkhamer, P. J., Crommelin, M. A., and Coebergh, J. W.
Improvement and plateau in survival of small-cell lung cancer since 1975: a population-based study.
Ann.Oncol. 9[5], 543-547. 1998.
106. Janssen-Heijnen, M. L. and Coebergh, J. W.
Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe.
Lung Cancer 31[2-3], 123-137. 2001.
107. Jassem, J., Skokowski, J., Dziadziuszko, R., Jassem, E., Szymanowska, A., Rzyman, W., and Roszkiewicz, A.
Results of surgical treatment of non-small cell lung cancer: validation of the new postoperative pathologic TNM classification.
J.Thorac.Cardiovasc.Surg. 119[6], 1141-1146. 2000.
108. Jefferson, M. F., Pendleton, N., Faragher, E. B., Dixon, G. R., Myskow, M. W., and Horan, M. A.
'Tumour volume' as a predictor of survival after resection of non-small-cell lung cancer (NSCLC).
Br.J.Cancer 74[3], 456-459. 1996.
109. Kallan, J.
Effects of sociodemographic variables on adult mortality in the United States: comparisons by sex, age, and cause of death [published erratum appears in Soc Biol 1997 Fall-Winter 44(3-4):294].
Soc.Biol. 44[1-2], 136-147. 1997.
110. Kawahara, M., Fukuoka, M., Saijo, N., Nishiwaki, Y., Ikegami, H., Tamura, T., Shimoyama, M., Suemasu, K., and Furuse, K.
Prognostic factors and prognostic staging system for small cell lung cancer.
Jpn.J.Clin.Oncol. 27[3], 158-165. 1997.
111. Kayser, K., Altiner, M., Dienemann, H., and Gabius, H. J.
Changes during the last decade in clinical parameters of operated lung carcinoma patients of a center for thoracic surgery and the prognostic significance of TNM, morphometric, cytometric, and glycohistochemical properties.
Thorac.Cardiovasc.Surg. 45[4], 196-199. 1997.
112. Keagy, B. A., Lores, M. E., Starek, P. J., Murray, G. F., Lucas, C. L., and Wilcox, B. R.
Elective pulmonary lobectomy: factors associated with morbidity and operative mortality.
Ann.Thorac.Surg. 40[4], 349-352. 1985.
113. Kearney, D. J., Lee, T. H., Reilly, J. J., DeCamp, M. M., and Sugarbaker, D. J.
Assessment of operative risk in patients undergoing lung resection. Importance of predicted pulmonary function.
Chest 105[3], 753-759. 1994.
114. Kern, K. A.
Medicolegal analysis of the delayed diagnosis of cancer in 338 cases in the United States.
Arch.Surg. 129[4], 397-403. 1994.
115. Kessler, R., Gasser, B., Massard, G., Roeslin, N., Meyer, P., Wihlm, J. M., and Morand, G.
Blood vessel invasion is a major prognostic factor in resected non-small cell lung cancer.
Ann.Thorac.Surg. 62[5], 1489-1493. 1996.
116. Kirsh, W. D. and Lee, R.
Disease management. Decreasing cost and increasing patient satisfaction: the implementation of a cancer disease management program.
Manag.Care Interface 12[8], 65-68. 1999.
117. Klemperer, J. and Ginsberg, R. J.
Morbidity and mortality after pneumonectomy.
Chest Surg.Clin.N.Am. 9[3], 515-25,vii. 1999.
118. Knott-Craig, C. J., Howell, C. E., Parsons, B. D., Paulsen, S. M., Brown, B. R., and Elkins, R. C.
Improved results in the management of surgical candidates with lung cancer.
Ann.Thorac.Surg. 63[5], 1405-1409. 1997.
119. Kohman, L. J., Meyer, J. A., Ikins, P. M., and Oates, R. P.
Random versus predictable risks of mortality after thoracotomy for lung cancer.
J.Thorac.Cardiovasc.Surg. 91[4], 551-554. 1986.
120. Komaki, R., Pajak, T. F., Byhardt, R. W., Emami, B., Asbell, S. O., Roach, M., III, Pedersen, J. E., Curran-WJ, Jr, Lattin, P., Russell, A. H., and et, al.
Analysis of early and late deaths on RTOG non-small cell carcinoma of the lung trials: comparison with CALGB 8433.
Lung Cancer 10[3-4], 189-197. 1993.
121. Kotlyarov, E. V. and Rukosuyev, A. A.
Long-term results and patterns of disease recurrence after radical operations for lung cancer.
J.Thorac.Cardiovasc.Surg. 102[1], 24-28. 1991.
122. Koukourakis, M., Hlouverakis, G., Kosma, L., Skarlatos, J., Damilakis, J., Giatromanolaki, A., and Yannakakis, D.
The impact of overall treatment time on the results of radiotherapy for nonsmall cell lung carcinoma.
Int.J.Radiat.Oncol.Biol.Phys. 34[2], 315-322. 15-1-1996.
123. Laroche, C., Wells, F., Coulden, R., Stewart, S., Goddard, M., Lowry, E., Price, A., and Gilligan, D.
Improving surgical resection rate in lung cancer [see comments].
Thorax 53[6], 445-449. 1998.
124. Laroche, C., Wells, F., Coulden, R., Stewart, S., Goddard, M., Lowry, E., Price, A., and Gilligan, D.
Improving surgical resection rate in lung cancer.
Thorax 53[6], 445-449. 1998.
125. Lassen, U., Osterlind, K., Hansen, M., Dombernowsky, P., Bergman, B., and Hansen, H. H.
Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients.
J.Clin.Oncol. 13[5], 1215-1220. 1995.
Elective pulmonary lobectomy: factors associated with morbidity and operative mortality.
Ann.Thorac.Surg. 40[4], 349-352. 1985.
113. Kearney, D. J., Lee, T. H., Reilly, J. J., DeCamp, M. M., and Sugarbaker, D. J.
Assessment of operative risk in patients undergoing lung resection. Importance of predicted pulmonary function.
Chest 105[3], 753-759. 1994.
114. Kern, K. A.
Medicolegal analysis of the delayed diagnosis of cancer in 338 cases in the United States.
Arch.Surg. 129[4], 397-403. 1994.
115. Kessler, R., Gasser, B., Massard, G., Roeslin, N., Meyer, P., Wihlm, J. M., and Morand, G.
Blood vessel invasion is a major prognostic factor in resected non-small cell lung cancer.
Ann.Thorac.Surg. 62[5], 1489-1493. 1996.
116. Kirsh, W. D. and Lee, R.
Disease management. Decreasing cost and increasing patient satisfaction: the implementation of a cancer disease management program.
Manag.Care Interface 12[8], 65-68. 1999.
117. Klemperer, J. and Ginsberg, R. J.
Morbidity and mortality after pneumonectomy.
Chest Surg.Clin.N.Am. 9[3], 515-25,vii. 1999.
118. Knott-Craig, C. J., Howell, C. E., Parsons, B. D., Paulsen, S. M., Brown, B. R., and Elkins, R. C.
Improved results in the management of surgical candidates with lung cancer.
Ann.Thorac.Surg. 63[5], 1405-1409. 1997.
119. Kohman, L. J., Meyer, J. A., Ikins, P. M., and Oates, R. P.
Random versus predictable risks of mortality after thoracotomy for lung cancer.
J.Thorac.Cardiovasc.Surg. 91[4], 551-554. 1986.
120. Komaki, R., Pajak, T. F., Byhardt, R. W., Emami, B., Asbell, S. O., Roach, M., III, Pedersen, J. E., Curran-WJ, Jr, Lattin, P., Russell, A. H., and et, al.
Analysis of early and late deaths on RTOG non-small cell carcinoma of the lung trials: comparison with CALGB 8433.
Lung Cancer 10[3-4], 189-197. 1993.
121. Kotlyarov, E. V. and Rukosuyev, A. A.
Long-term results and patterns of disease recurrence after radical operations for lung cancer.
J.Thorac.Cardiovasc.Surg. 102[1], 24-28. 1991.
122. Koukourakis, M., Hlouverakis, G., Kosma, L., Skarlatos, J., Damilakis, J., Giatromanolaki, A., and Yannakakis, D.
The impact of overall treatment time on the results of radiotherapy for nonsmall cell lung carcinoma.
Int.J.Radiat.Oncol.Biol.Phys. 34[2], 315-322. 15-1-1996.
123. Laroche, C., Wells, F., Coulden, R., Stewart, S., Goddard, M., Lowry, E., Price, A., and Gilligan, D.
Improving surgical resection rate in lung cancer [see comments].
Thorax 53[6], 445-449. 1998.
124. Laroche, C., Wells, F., Coulden, R., Stewart, S., Goddard, M., Lowry, E., Price, A., and Gilligan, D.
Improving surgical resection rate in lung cancer.
Thorax 53[6], 445-449. 1998.
125. Lassen, U., Osterlind, K., Hansen, M., Dombernowsky, P., Bergman, B., and Hansen, H. H.
Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients.
J.Clin.Oncol. 13[5], 1215-1220. 1995.
126. Lassen, U., Kristjansen, P. E., Osterlind, K., Bergman, B., Sigsgaard, T. C., Hirsch, F. R., Hansen, M., Dombernowsky, P., and Hansen, H. H.
Superiority of cisplatin or carboplatin in combination with teniposide and vincristine in the induction chemotherapy of small-cell lung cancer. A randomized trial with 5 years follow up.
Ann.Oncol. 7[4], 365-371. 1996.
127. Lassen, U. N., Hirsch, F. R., Osterlind, K., Bergman, B., and Dombernowsky, P.
Outcome of combination chemotherapy in extensive stage small-cell lung cancer: any treatment related progress?
Lung Cancer 20[3], 151-160. 1998.
128. Law, M. R. and Morris, J. K.
Why is mortality higher in poorer areas and in more northern areas of England and Wales?
J.Epidemiol.Community Health 52[6], 344-352. 1998.
129. Le Chevalier, T., Brisgand, D., Soria, J. C., Douillard, J. Y., Pujol, J. L., Ruffie, P., Aberola, V., and Cigolari, S.
Long term analysis of survival in the European randomized trial comparing vinorelbine/cisplatin to vindesine/cisplatin and vinorelbine alone in advanced non-small cell lung cancer.
Oncologist. 6 Suppl 1, 8-11. 2001.
130. Levi, F., Lucchini, F., Negri, E., Boyle, P., and La Vecchia, C.
Cancer mortality in Europe, 1990-1994, and an overview of trends from 1955 to 1994.
Eur.J.Cancer 35[10], 1477-1516. 1999.
131. Licker, M., de Perrot, M., Hohn, L., Tschopp, J. M., Robert, J., Frey, J. G., Schweizer, A., and Spiliopoulos, A.
Perioperative mortality and major cardio-pulmonary complications after lung surgery for non-small cell carcinoma.
Eur.J.Cardiothorac.Surg. 15[3], 314-319. 1999.
132. Lilenbaum, R. C., Langenberg, P., and Dickersin, K.
Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: a meta-analysis of response, toxicity, and survival.
Cancer 82[1], 116-126. 1-1-1998.
Superiority of cisplatin or carboplatin in combination with teniposide and vincristine in the induction chemotherapy of small-cell lung cancer. A randomized trial with 5 years follow up.
Ann.Oncol. 7[4], 365-371. 1996.
127. Lassen, U. N., Hirsch, F. R., Osterlind, K., Bergman, B., and Dombernowsky, P.
Outcome of combination chemotherapy in extensive stage small-cell lung cancer: any treatment related progress?
Lung Cancer 20[3], 151-160. 1998.
128. Law, M. R. and Morris, J. K.
Why is mortality higher in poorer areas and in more northern areas of England and Wales?
J.Epidemiol.Community Health 52[6], 344-352. 1998.
129. Le Chevalier, T., Brisgand, D., Soria, J. C., Douillard, J. Y., Pujol, J. L., Ruffie, P., Aberola, V., and Cigolari, S.
Long term analysis of survival in the European randomized trial comparing vinorelbine/cisplatin to vindesine/cisplatin and vinorelbine alone in advanced non-small cell lung cancer.
Oncologist. 6 Suppl 1, 8-11. 2001.
130. Levi, F., Lucchini, F., Negri, E., Boyle, P., and La Vecchia, C.
Cancer mortality in Europe, 1990-1994, and an overview of trends from 1955 to 1994.
Eur.J.Cancer 35[10], 1477-1516. 1999.
131. Licker, M., de Perrot, M., Hohn, L., Tschopp, J. M., Robert, J., Frey, J. G., Schweizer, A., and Spiliopoulos, A.
Perioperative mortality and major cardio-pulmonary complications after lung surgery for non-small cell carcinoma.
Eur.J.Cardiothorac.Surg. 15[3], 314-319. 1999.
132. Lilenbaum, R. C., Langenberg, P., and Dickersin, K.
Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: a meta-analysis of response, toxicity, and survival.
Cancer 82[1], 116-126. 1-1-1998.
133. Little, A. G. and Stitik, F. P.
Clinical staging of patients with non-small cell lung cancer.
Chest 97[6], 1431-1438. 1990.
134. Liu, N. S., Spitz, M. R., Kemp, B. L., Cooksley, C., Fossella, F. V., Lee, J. S., Hong, W. K., and Khuri, F. R.
Adenocarcinoma of the lung in young patients: the M. D. Anderson experience.
Cancer 88[8], 1837-1841. 15-4-2000.
Clinical staging of patients with non-small cell lung cancer.
Chest 97[6], 1431-1438. 1990.
134. Liu, N. S., Spitz, M. R., Kemp, B. L., Cooksley, C., Fossella, F. V., Lee, J. S., Hong, W. K., and Khuri, F. R.
Adenocarcinoma of the lung in young patients: the M. D. Anderson experience.
Cancer 88[8], 1837-1841. 15-4-2000.
135. Loblaw, D. A., Bezjak, A., and Bunston, T.
Development and testing of a visit-specific patient satisfaction questionnaire: the Princess Margaret Hospital Satisfaction With Doctor Questionnaire.
J.Clin.Oncol. 17[6], 1931-1938. 1999.
136. Lopez, P. G., Stewart, D. J., Newman, T. E., and Evans, W. K.
Chemotherapy in stage IV (metastatic) non-small-cell lung cancer. Provincial Lung Disease Site Group.
Cancer Prev.Control 1[1], 18-27. 1997.
137. Luedke, D. W., Einhorn, L., Omura, G. A., Sarma, P. R., Bartolucci, A. A., Birch, R., and Greco, F. A.
Randomized comparison of two combination regimens versus minimal chemotherapy in nonsmall-cell lung cancer: a Southeastern Cancer Study Group Trial.
J.Clin.Oncol. 8[5], 886-891. 1990.
138. Macbeth, F. R., Bolger, J. J., Hopwood, P., Bleehen, N. M., Cartmell, J., Girling, D. J., Machin, D., Stephens, R. J., and Bailey, A. J.
Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Medical Research Council Lung Cancer Working Party.
Clin.Oncol.(R.Coll.Radiol.) 8[3], 167-175. 1996.
139. Mackillop, W. J., Fu, H., Quirt, C. F., Dixon, P., Brundage, M., and Zhou, Y.
Waiting for radiotherapy in Ontario.
Int.J.Radiat.Oncol.Biol.Phys. 30[1], 221-228. 30-8-1994.
140. Maestu, I., Pastor, M., Gomez-Codina, J., Aparicio, J., Oltra, A., Herranz, C., Montalar, J., Munarriz, B., and Reynes, G.
Pretreatment prognostic factors for survival in small-cell lung cancer: a new prognostic index and validation of three known prognostic indices on 341 patients.
Ann.Oncol. 8[6], 547-553. 1997.
141. Maggi, G., Casadio, C., Mancuso, M., Oliaro, A., Cianci, R., and Ruffini, E.
Resection and radical lymphadenectomy for lung cancer: prognostic significance of lymphatic metastases.
Int.Surg. 75[1], 17-21. 1990.
142. Malmberg, R., Bergman, B., Branehog, I., Larsson, S., Olling, S., and Wernstedt, L.
Lung cancer in West Sweden 1976-1985. A study of trends and survival with special reference to surgical treatment.
Acta Oncol. 35[2], 185-192. 1996.
143. Mansson, J., Bjorkelund, C., and Hultborn, R.
Symptom pattern and diagnostic work-up of malignancy at first symptom presentation as related to level of care. A retrospective study from the primary health care centre area of Kungsbacka, Sweden.
Neoplasma 46[2], 93-99. 1999.
144. Marino, P., Pampallona, S., Preatoni, A., Cantoni, A., and Invernizzi, F.
Chemotherapy vs supportive care in advanced non-small-cell lung cancer. Results of a meta-analysis of the literature [see comments].
Chest 106[3], 861-865. 1994.
145. Marino, P., Preatoni, A., and Cantoni, A.
Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis [see comments].
Cancer 76[4], 593-601. 15-8-1995.
146. Marino, P., Preatoni, A., Cantoni, A., and Buccheri, G.
Single-agent chemotherapy versus combination chemotherapy in advanced non-small cell lung cancer: a quality and meta-analysis study.
Lung Cancer 13[1], 1-12. 1995.
147. Martini N.
Surgical treatment of non-small cell lung cancer by stage.
Semin Surg Oncol 1990 6, 248-254. 2001.
148. Martini N and et al.
Survival after resection in stade II non small-cell-lung cancer.
Ann Thorac surg 1992 54, 460. 2001.
149. Martini, N., Rusch, V. W., Bains, M. S., Kris, M. G., Downey, R. J., Flehinger, B. J., and Ginsberg, R. J.
Factors influencing ten-year survival in resected stages I to IIIa non-small cell lung cancer.
J.Thorac.Cardiovasc.Surg. 117[1], 32-36. 1999.
150. Martins, S. J. and Pereira, J. R.
Clinical factors and prognosis in non-small cell lung cancer.
Am.J.Clin.Oncol. 22[5], 453-457. 1999.
151. Mattson, K.
Docetaxel (Taxotere) and neoadjuvant chemotherapy for non-small cell lung cancer.
Semin.Oncol. 26[3 Suppl 10], 25-28. 1999.
152. McCarthy, E. P., Phillips, R. S., Zhong, Z., Drews, R. E., and Lynn, J.
Dying with cancer: patients' function, symptoms, and care preferences as death approaches.
J.Am.Geriatr.Soc. 48[5 Suppl], S110-S121. 2000.
153. McLean, A. N., Semple, P. A., Franklin, D. H., Petrie, G., Millar, E. A., and Douglas, J. G.
The Scottish multi-centre prospective study of bronchoscopy for bronchial carcinoma and suggested audit standards.
Respir.Med. 92[9], 1110-1115. 1998.
154. McLean, A. N., Douglas, J. G., and Semple, P. D.
Scottish national bronchoscopy audit: a prospective multicentre study of 3316 cases against agreed standards. Scottish Thoracic Society.
Respir.Med. 94[5], 511-515. 2000.
155. McWhinney, I. R., Bass, M. J., and Orr, V.
Factors associated with location of death (home or hospital) of patients referred to a palliative care team.
CMAJ. 152[3], 361-367. 1-2-1995.
156. Mercadante, S., Maddaloni, S., Roccella, S., and Salvaggio, L.
Predictive factors in advanced cancer pain treated only by analgesics.
Pain 50[2], 151-155. 1992.
157. Mercadante, S., Armata, M., and Salvaggio, L.
Pain characteristics of advanced lung cancer patients referred to a palliative care service.
Pain 59[1], 141-145. 1994.
158. Miaskowski, C., Nichols, R., Brody, R., and Synold, T.
Assessment of patient satisfaction utilizing the American Pain Society's Quality Assurance Standards on acute and cancer-related pain.
J.Pain Symptom.Manage. 9[1], 5-11. 1994.
159. Miller, A. A., Herndon, J. E., Hollis, D. R., Ellerton, J., Langleben, A., Richards, F., and Green, M. R.
Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: a randomized phase III study of the Cancer and Leukemia Group B.
J.Clin.Oncol. 13[8], 1871-1879. 1995.
160. Monson, J. M., Stark, P., Reilly, J. J., Sugarbaker, D. J., Strauss, G. M., Swanson, S. J., DeCamp, M. M., Mentzer, S. J., and Baldini, E. H.
Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma.
Cancer 82[5], 842-850. 1-3-1998.
161. Montazeri, A., Milroy, R., Gillis, C. R., and McEwen, J.
Interviewing cancer patients in a research setting: the role of effective communication.
Support.Care Cancer 4[6], 447-454. 1996.
162. Montazeri, A., Milroy, R., Hole, D., McEwen, J., and Gillis, C. R.
Quality of life in lung cancer patients. As an important prognostic factor.
Lung Cancer 31[2-3], 233-240. 2001.
163. Mor, V., Masterson-Allen, S., Goldberg, R., Guadagnoli, E., and Wool, M. S.
Pre-diagnostic symptom recognition and help seeking among cancer patients.
J.Community Health 15[4], 253-266. 1990.
164. Motta, G. and Ratto, G. B.
Complications of surgery in the treatment of lung cancer: their relationship with the extent of resection and preoperative respiratory function tests.
Acta Chir Belg. 89[3], 161-165. 1989.
165. Mountain, C. F. and Dresler, C. M.
Regional lymph node classification for lung cancer staging.
Chest 111[6], 1718-1723. 1997.
166. Mountain, C. F.
Revisions in the International System for Staging Lung Cancer.
Chest 111[6], 1710-1717. 1997.
167. Mountain, C. F.
The international system for staging lung cancer.
Semin.Surg.Oncol. 18[2], 106-115. 2000.
168. Muers, M. F. and Round, C. E.
Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organisation Thoracic Group.
Thorax 48[4], 339-343. 1993.
169. Naruke, T., Tsuchiya, R., Kondo, H., Asamura, H., and Nakayama, H.
Implications of staging in lung cancer.
Chest 112[4 Suppl], 242S-248S. 1997.
170. Newaishy, G. A. and Kelly, C. G.
An audit of survival in small cell lung cancer.
Clin.Oncol.R.Coll.Radiol. 4[6], 362-367. 1992.
171. Okada, M., Yoshikawa, K., Hatta, T., and Tsubota, N.
Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller?
Ann.Thorac.Surg. 71[3], 956-960. 2001.
172. Okawara, G., Rusthoven, J., Newman, T., Findlay, B., and Evans, W.
Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
Cancer Prev.Control 1[3], 249-259. 1997.
173. Paesmans, M., Sculier, J. P., Lecomte, J., Thiriaux, J., Libert, P., Sergysels, R., Bureau, G., Dabouis, G., Van Cutsem, O., Mommen, P., Ninane, V., and Klastersky, J.
Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years.
Cancer 89[3], 523-533. 1-8-2000.
174. Page, A., Nakhle, G., Mercier, C., Verdant, A., Page, P., Dontigny, L., Allard, S., Gauthier, J. J., and Cossette, R.
Surgical treatment of bronchogenic carcinoma: the importance of staging in evaluating late survival.
Can.J.Surg. 30[2], 96-99. 1987.
175. Palazzi, M., Villa, S., Leonardi, M. C., and Milani, F.
Indications, results and techniques of radiotherapy in the treatment of small-cell lung cancer.
Tumori 82[4], 345-352. 1996.
176. Parquin, F., Marchal, M., Mehiri, S., Herve, P., and Lescot, B.
Post-pneumonectomy pulmonary edema: analysis and risk factors.
Eur.J.Cardiothorac.Surg. 10[11], 929-932. 1996.
177. Patel, R. L., Townsend, E. R., and Fountain, S. W.
Elective pneumonectomy: factors associated with morbidity and operative mortality.
Ann.Thorac.Surg. 54[1], 84-88. 1992.
178. Pater, J. L., Zee, B., Palmer, M., Johnston, D., and Osoba, D.
Fatigue in patients with cancer: results with National Cancer Institute of Canada Clinical Trials Group studies employing the EORTC QLQ-C30.
Support.Care Cancer 5[5], 410-413. 1997.
179. Patz, E. F., Rossi, S., Harpole, D. H., Herndon, J. E., and Goodman, P. C.
Correlation of tumor size and survival in patients with stage IA non-small cell lung cancer.
Chest 117[6], 1568-1571. 2000.
180. Pignon, J. P., Arriagada, R., Ihde, D. C., Johnson, D. H., Perry, M. C., Souhami, R. L., Brodin, O., Joss, R. A., Kies, M. S., Lebeau, B., and et, al.
A meta-analysis of thoracic radiotherapy for small-cell lung cancer [see comments].
N.Engl.J.Med. 327[23], 1618-1624. 3-12-1992.
181. Pignon, T., Gregor, A., Schaake, Koning C., Roussel, A., Van Glabbeke, M., and Scalliet, P.
Age has no impact on acute and late toxicity of curative thoracic radiotherapy.
Radiother.Oncol. 46[3], 239-248. 1998.
182. Porta, M., Gallen, M., Malats, N., and Planas, J.
Influence of "diagnostic delay" upon cancer survival: an analysis of five tumour sites.
J.Epidemiol.Community Health 45[3], 225-230. 1991.
183. Porte, H., Siat, J., Guibert, B., Lepimpec-Barthes, F., Jancovici, R., Bernard, A., Foucart, A., and Wurtz, A.
Resection of adrenal metastases from non-small cell lung cancer: a multicenter study.
Ann.Thorac.Surg. 71[3], 981-985. 2001.
184. Portenoy, R. K., Miransky, J., Thaler, H. T., Hornung, J., Bianchi, C., Cibas-Kong, I., Feldhamer, E., Lewis, F., Matamoros, I., Sugar, M. Z., and .
Pain in ambulatory patients with lung or colon cancer. Prevalence, characteristics, and effect.
Cancer 70[6], 1616-1624. 15-9-1992.
185. Prescott, E., Osler, M., Andersen, P. K., Hein, H. O., Borch, Johnsen K., Lange, P., Schnohr, P., and Vestbo, J.
Mortality in women and men in relation to smoking.
Int.J.Epidemiol. 27[1], 27-32. 1998.
186. Radford, J. A., Ryder, W. D., Dodwell, D., Anderson, H., and Thatcher, N.
Predicting septic complications of chemotherapy: an analysis of 382 patients treated for small cell lung cancer without dose reduction after major sepsis.
Eur.J.Cancer 29A[1], 81-86. 1992.
187. Recine, D., Rowland, K., Reddy, S., Lee, M. S., Bonomi, P., Taylor, S., Faber, L. P., Warren, W., Kittle, C. F., and Hendrickson, F. R.
Combined modality therapy for locally advanced non-small cell lung carcinoma.
Cancer 66[11], 2270-2278. 1-12-1990.
188. Reif, M. S., Socinski, M. A., and Rivera, M. P.
Evidence-based medicine in the treatment of non-small-cell lung cancer.
Clin.Chest Med. 21[1], 107-20, ix. 2000.
189. Rens MTM van, Rivière AB de la, and et al.
Prognostic assessment of 2.361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II and IIIA
82.
Chest 2000 117, 374-379. 2001.
190. Rice, T. W., Adelstein, D. J., Koka, A., Tefft, M., Kirby, T. J., Van Kirk, M. A., Taylor, M. E., Olencki, T. E., Peereboom, D., and Budd, G. T.
Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancer.
Ann.Thorac.Surg. 60[3], 586-591. 1995.
191. Ringbaek, T., Borgeskov, S., Lange, P., and Viskum, K.
Diagnostic and therapeutic process and prognosis in suspected lung cancer.
Scand.Cardiovasc.J. 33[6], 337-343. 1999.
192. Ringbaek, T. J., Borgeskov, S., Lange, P., and Viskum, K.
[Therapeutic and prognostic course in patients with suspected lung cancer. Results of combined thoracic surgery-pulmonary medicine evaluation].
Ugeskr.Laeger 160[2], 170-175. 5-1-1998.
193. Robnett, T. J., Machtay, M., Vines, E. F., McKenna, M. G., Algazy, K. M., and McKenna, W. G.
Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer.
Int.J.Radiat.Oncol.Biol.Phys. 48[1], 89-94. 1-8-2000.
194. Rose, J. H., O'Toole, E. E., Dawson, N. V., Thomas, C., Connors, A. F., Wenger, N. S., Phillips, R. S., Hamel, M. B., Cohen, H. J., and Lynn, J.
Age differences in care practices and outcomes for hospitalized patients with cancer.
J.Am.Geriatr.Soc. 48[5 Suppl], S25-S32. 2000.
195. Rose, J. H., O'Toole, E. E., Dawson, N. V., Thomas, C., Connors, A. F., Wenger, N., Phillips, R. S., Hamel, M. B., Reding, D. T., Cohen, H. J., and Lynn, J.
Generalists and oncologists show similar care practices and outcomes for hospitalized late-stage cancer patients. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks for Treatment.
Med.Care 38[11], 1103-1118. 2000.
196. Sagman, U., Maki, E., Evans, W. K., Warr, D., Shepherd, F. A., Sculier, J. P., Haddad, R., Payne, D., Pringle, J. F., and Yeoh, J. L.
Small-cell carcinoma of the lung: derivation of a prognostic staging system.
J.Clin.Oncol. 9[9], 1639-1649. 1991.
197. Sandler, A. B.
Current management of small cell lung cancer.
Semin.Oncol. 24[4], 463-476. 1997.
198. Sandler, A. B., Nemunaitis, J., Denham, C., von Pawel, J., Cormier, Y., Gatzemeier, U., Mattson, K., Manegold, C., Palmer, M. C., Gregor, A., Nguyen, B., Niyikiza, C., and Einhorn, L. H.
Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer.
J.Clin.Oncol. 18[1], 122-130. 2000.
199. Saunders, M., Dische, S., Barrett, A., Harvey, A., Gibson, D., and Parmar, M.
Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee [see comments].
Lancet 350[9072], 161-165. 19-7-1997.
200. Sawyer, T. E., Bonner, J. A., Gould, P. M., Foote, R. L., Deschamps, C., Trastek, V. F., Pairolero, P. C., Allen, M. S., Lange, C. M., and Li, H.
Effectiveness of postoperative irradiation in stage IIIA non-small cell lung cancer according to regression tree analyses of recurrence risks.
Ann.Thorac.Surg. 64[5], 1402-1407. 1997.
201. Sessa, C., Roggero, E., Pampallona, S., Regazzoni, S., Ghielmini, M., Lang, M., Marx, B., Neuenschwander, H., Pagani, O., Vasilievic, V., and Cavalli, F.
The last 3 months of life of cancer patients: medical aspects and role of home-care services in southern Switzerland [see comments].
Support.Care Cancer 4[3], 180-185. 1996.
202. Shah, R., Sabanathan, S., Richardson, J., Mearns, A. J., and Goulden, C.
Results of surgical treatment of stage I and II lung cancer.
J.Cardiovasc.Surg.Torino 37[2], 169-172. 1996.
203. Shepherd, F. A.
The role of chemotherapy in the treatment of small cell lung cancer.
Chest Surg.Clin.N.Am. 7[1], 113-133. 1997.
204. Silvestri, G., Pritchard, R., and Welch, H. G.
Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews.
BMJ 317[7161], 771-775. 19-9-1998.
205. Simpson, J. R., Bauer, M., Wasserman, T. H., Perez, C. A., Emami, B., Wiegensberg, I., Zinninger, M., and Durbin, L. M.
Large fraction irradiation with or without misonidazole in advanced non-oat cell carcinoma of the lung: a phase III randomized trial of the RTOG. Radiation Therapy Oncology Group.
Int.J.Radiat.Oncol.Biol.Phys. 13[6], 861-867. 1987.
206. Sitzia, J. and Wood, N.
Patient satisfaction with cancer chemotherapy nursing: a review of the literature.
Int.J.Nurs.Stud. 35[1-2], 1-12. 1998.
207. Smeenk, F. W., van Haastregt, J. C., de Witte, L. P., and Crebolder, H. F.
Effectiveness of home care programmes for patients with incurable cancer on their quality of life and time spent in hospital: systematic review.
BMJ 316[7149], 1939-1944. 27-6-1998.
208. Sorensen, J. B., Badsberg, J. H., and Olsen, J.
Prognostic factors in inoperable adenocarcinoma of the lung: a multivariate regression analysis of 259 patients.
Cancer Res. 49[20], 5748-5754. 15-10-1989.
209. Souquet, P. J., Chauvin, F., Boissel, J. P., Cellerino, R., Cormier, Y., Ganz, P. A., Kaasa, S., Pater, J. L., Quoix, E., and Rapp, E.
Polychemotherapy in advanced non small cell lung cancer: a meta-analysis [see comments].
Lancet 342[8862], 19-21. 3-7-1993.
210. Sridhar, K. S., Raub, W., Duncan, R. C., Hilsenbeck, S., and Richman, S. P.
Lung carcinoma in 1,336 patients
164.
Am.J.Clin.Oncol. 14[6], 496-508. 1991.
211. Steinbaum, S. S., Uretzky, I. D., McAdams, H. P., Torrington, K. G., and Cohen, A. J.
Exploratory thoracotomy for nonresectable lung cancer.
Chest 107[4], 1058-1061. 1995.
212. Stephens, R. J., Girling, D. J., Bleehen, N. M., Moghissi, K., Yosef, H. M., and Machin, D.
The role of post-operative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Medical Research Council Lung Cancer Working Party.
Br.J.Cancer 74[4], 632-639. 1996.
213. Storm, H. H., Dickman, P. W., Engeland, A., Haldorsen, T., and Hakulinen, T.
Do morphology and stage explain the inferior lung cancer survival in Denmark?
Eur.Respir.J. 13[2], 430-435. 1999.
214. Sugiura, S., Ando, Y., Minami, H., Ando, M., Sakai, S., and Shimokata, K.
Prognostic value of pleural effusion in patients with non-small cell lung cancer.
Clin.Cancer Res. 3[1], 47-50. 1997.
215. Suzuki, K., Nagai, K., Yoshida, J., Nishimura, M., Takahashi, K., Yokose, T., and Nishiwaki, Y.
Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma. A comparison of prognostic factors for each pathologic TNM stage based on multivariate analyses.
Cancer 86[10], 1976-1984. 15-11-1999.
216. Suzuki, K., Nagai, K., Yoshida, J., Nishimura, M., Takahashi, K., and Nishiwaki, Y.
The prognosis of surgically resected N2 non-small cell lung cancer: the importance of clinical N status.
J.Thorac.Cardiovasc.Surg. 118[1], 145-153. 1999.
217. Suzuki, K., Nagai, K., Yoshida, J., Moriyama, E., Nishimura, M., Takahashi, K., and Nishiwaki, Y.
Prognostic factors in clinical stage I non-small cell lung cancer.
Ann.Thorac.Surg. 67[4], 927-932. 1999.
218. Tamura, M., Ueoka, H., Kiura, K., Tabata, M., Shibayama, T., Miyatake, K., Gemba, K., Hiraki, S., and Harada, M.
Prognostic factors of small-cell lung cancer in Okayama Lung Cancer Study Group Trials [see comments].
Acta Med.Okayama 52[2], 105-111. 1998.
219. Tanaka, F., Yanagihara, K., Otake, Y., Miyahara, R., Kawano, Y., Nakagawa, T., Shoji, T., and Wada, H.
Surgery for non-small cell lung cancer: postoperative survival based on the revised tumor-node-metastasis classification and its time trend.
Eur.J.Cardiothorac.Surg. 18[2], 147-155. 2000.
220. Teo, P., Tai, T. H., Choy, D., and Tsui, K. H.
A randomized study on palliative radiation therapy for inoperable non small cell carcinoma of the lung.
Int.J.Radiat.Oncol.Biol.Phys. 14[5], 867-871. 1988.
221. Thoren-Todoulos, E.
[Psychosocial factors are limiting the possibility of dying at home].
Lakartidningen 96[5], 472-475. 3-2-1999.
222. Urban, T., Chastang, C., Lebas, F. X., Duhamel, J. P., Adam, G., Darse, J., Brechot, J. M., and Lebeau, B.
The addition of cisplatin to cyclophosphamide-doxorubicin-etoposide combination chemotherapy in the treatment of patients with small cell lung carcinoma: A randomized study of 457 patients. "Petites Cellules" Group.
Cancer 86[11], 2238-2245. 1-12-1999.
223. Valente, M., Pastorino, U., Piva, L., Guzzon, A., and Ravasi, G.
Post-thoracotomy diagnostic and staging conversion rates of clinically staged I lung cancer.
Tumori 67[3], 239-243. 1981.
224. van Den Bosch, J. M., Gelissen, H. J., and Wagenaar, S. S.
Exploratory thoracotomy in bronchial carcinoma.
J.Thorac.Cardiovasc.Surg. 85[5], 733-737. 1983.
225. Van Raemdonck DE, Schneider A, and et al.
Surgical treatment for higher stage non-small cell lung cancer.
Ann Thorac surg 1992 54, 999-1013. 2001.
226. van Rens, M. T., de la Riviere, A. B., Elbers, H. R., and van Den Bosch, J. M.
Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA.
Chest 117[2], 374-379. 2000.
227. Vansteenkiste, J., De Leyn, P., Deneffe, G., Menten, J., Lerut, T., and Demedts, M.
Present status of induction treatment in stage IIIA-N2 non-small cell lung cancer: a review. The Leuven Lung Cancer Group.
Eur.J.Cardiothorac.Surg. 13[1], 1-12. 1998.
228. Vansteenkiste, J. F., De Leyn, P. R., Deneffe, G. J., Lerut, T. E., and Demedts, M. G.
systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group [see comments].
[9124], -63. 98.
229. Wada, H., Fukuse, T., and Hitomi, S.
Long-term survival of surgical cases of lung cancer.
Lung Cancer 13[3], 269-274. 1995.
230. Wada, H., Hitomi, S., and Teramatsu, T.
Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery [see comments].
J.Clin.Oncol. 14[4], 1048-1054. 1996.
231. Wada, H., Tanaka, F., Yanagihara, K., Ariyasu, T., Fukuse, T., Yokomise, H., Inui, K., Mizuno, H., Ike, O., and Hitomi, S.
Time trends and survival after operations for primary lung cancer from 1976 through 1990.
J.Thorac.Cardiovasc.Surg. 112[2], 349-355. 1996.
232. Wada, H., Nakamura, T., Nakamoto, K., Maeda, M., and Watanabe, Y.
Thirty-day operative mortality for thoracotomy in lung cancer.
J.Thorac.Cardiovasc.Surg. 115[1], 70-73. 1998.
233. Wahi, R., McMurtrey, M. J., DeCaro, L. F., Mountain, C. F., Ali, M. K., Smith, T. L., and Roth, J. A.
Determinants of perioperative morbidity and mortality after pneumonectomy.
Ann.Thorac.Surg. 48[1], 33-37. 1989.
234. Waller, D. A., Gebitekin, C., Saunders, N. R., and Walker, D. R.
Noncardiogenic pulmonary edema complicating lung resection.
Ann.Thorac.Surg. 55[1], 140-143. 1993.
235. Walsh, G. L., O'Connor, M., Willis, K. M., Milas, M., Wong, R. S., Nesbitt, J. C., Putnam, J. B., Lee, J. J., and Roth, J. A.
Is follow-up of lung cancer patients after resection medically indicated and cost-effective?
Ann.Thorac.Surg. 60[6], 1563-1570. 1995.
236. Watanabe, Y., Murakami, S., Oda, M., Ohta, Y., Watanabe, S., Nozawa, H., Kamesui, T., Nozaki, Y., Nonomura, A., Minato, H., and Kitagawa, M.
Tumor size and extension of lymph node metastases in N2 lung cancer.
Ann.Ital.Chir 70[6], 889-892. 1999.
237. Watson, P. N. and Evans, R. J.
Intractable pain with lung cancer.
Pain 29[2], 163-173. 1987.
238. Wertzel, H., Siebert, H., Lange, W., Swoboda, L., Graf, E., and Hasse, J.
Results after surgery in stage-I bronchogenic carcinoma.
Thorac.Cardiovasc.Surg. 46[6], 365-369. 1998.
239. Wigren, T., Oksanen, H., and Kellokumpu, Lehtinen P.
A practical prognostic index for inoperable non-small-cell lung cancer [see comments].
J.Cancer Res.Clin.Oncol. 123[5], 259-266. 1997.
240. Wingo, P. A., Ries, L. A., Parker, S. L., and Heath-CW, Jr.
Long-term cancer patient survival in the United States [see comments].
Cancer Epidemiol.Biomarkers Prev. 7[4], 271-282. 1998.
241. Wolf, M., Holle, R., Hans, K., Drings, P., and Havemann, K.
Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): the role of sex as a predictor for survival.
Br.J.Cancer 63[6], 986-992. 1991.
242. Work E, Nielsen OS, and et al .
Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer
124.
J Clin Oncol 1997 15, 3030-3037. 2001.
243. Wurschmidt, F., Bunemann, H., Ehnert, M., and Heilmann, H. P.
Is the time interval between surgery and radiotherapy important in operable nonsmall cell lung cancer? A retrospective analysis of 340 cases.
Int.J.Radiat.Oncol.Biol.Phys. 39[3], 553-559. 1-10-1997.
244. Yip, D. and Harper, P. G.
Predictive and prognostic factors in small cell lung cancer: current status.
Lung Cancer 28[3], 173-185. 2000.
245. Zabora, J., BrintzenhofeSzoc, K., Curbow, B., Hooker, C., and Piantadosi, S.
The prevalence of psychological distress by cancer site.
Psychooncology. 10[1], 19-28. 2001.
Development and testing of a visit-specific patient satisfaction questionnaire: the Princess Margaret Hospital Satisfaction With Doctor Questionnaire.
J.Clin.Oncol. 17[6], 1931-1938. 1999.
136. Lopez, P. G., Stewart, D. J., Newman, T. E., and Evans, W. K.
Chemotherapy in stage IV (metastatic) non-small-cell lung cancer. Provincial Lung Disease Site Group.
Cancer Prev.Control 1[1], 18-27. 1997.
137. Luedke, D. W., Einhorn, L., Omura, G. A., Sarma, P. R., Bartolucci, A. A., Birch, R., and Greco, F. A.
Randomized comparison of two combination regimens versus minimal chemotherapy in nonsmall-cell lung cancer: a Southeastern Cancer Study Group Trial.
J.Clin.Oncol. 8[5], 886-891. 1990.
138. Macbeth, F. R., Bolger, J. J., Hopwood, P., Bleehen, N. M., Cartmell, J., Girling, D. J., Machin, D., Stephens, R. J., and Bailey, A. J.
Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Medical Research Council Lung Cancer Working Party.
Clin.Oncol.(R.Coll.Radiol.) 8[3], 167-175. 1996.
139. Mackillop, W. J., Fu, H., Quirt, C. F., Dixon, P., Brundage, M., and Zhou, Y.
Waiting for radiotherapy in Ontario.
Int.J.Radiat.Oncol.Biol.Phys. 30[1], 221-228. 30-8-1994.
140. Maestu, I., Pastor, M., Gomez-Codina, J., Aparicio, J., Oltra, A., Herranz, C., Montalar, J., Munarriz, B., and Reynes, G.
Pretreatment prognostic factors for survival in small-cell lung cancer: a new prognostic index and validation of three known prognostic indices on 341 patients.
Ann.Oncol. 8[6], 547-553. 1997.
141. Maggi, G., Casadio, C., Mancuso, M., Oliaro, A., Cianci, R., and Ruffini, E.
Resection and radical lymphadenectomy for lung cancer: prognostic significance of lymphatic metastases.
Int.Surg. 75[1], 17-21. 1990.
142. Malmberg, R., Bergman, B., Branehog, I., Larsson, S., Olling, S., and Wernstedt, L.
Lung cancer in West Sweden 1976-1985. A study of trends and survival with special reference to surgical treatment.
Acta Oncol. 35[2], 185-192. 1996.
143. Mansson, J., Bjorkelund, C., and Hultborn, R.
Symptom pattern and diagnostic work-up of malignancy at first symptom presentation as related to level of care. A retrospective study from the primary health care centre area of Kungsbacka, Sweden.
Neoplasma 46[2], 93-99. 1999.
144. Marino, P., Pampallona, S., Preatoni, A., Cantoni, A., and Invernizzi, F.
Chemotherapy vs supportive care in advanced non-small-cell lung cancer. Results of a meta-analysis of the literature [see comments].
Chest 106[3], 861-865. 1994.
145. Marino, P., Preatoni, A., and Cantoni, A.
Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis [see comments].
Cancer 76[4], 593-601. 15-8-1995.
146. Marino, P., Preatoni, A., Cantoni, A., and Buccheri, G.
Single-agent chemotherapy versus combination chemotherapy in advanced non-small cell lung cancer: a quality and meta-analysis study.
Lung Cancer 13[1], 1-12. 1995.
147. Martini N.
Surgical treatment of non-small cell lung cancer by stage.
Semin Surg Oncol 1990 6, 248-254. 2001.
148. Martini N and et al.
Survival after resection in stade II non small-cell-lung cancer.
Ann Thorac surg 1992 54, 460. 2001.
149. Martini, N., Rusch, V. W., Bains, M. S., Kris, M. G., Downey, R. J., Flehinger, B. J., and Ginsberg, R. J.
Factors influencing ten-year survival in resected stages I to IIIa non-small cell lung cancer.
J.Thorac.Cardiovasc.Surg. 117[1], 32-36. 1999.
150. Martins, S. J. and Pereira, J. R.
Clinical factors and prognosis in non-small cell lung cancer.
Am.J.Clin.Oncol. 22[5], 453-457. 1999.
151. Mattson, K.
Docetaxel (Taxotere) and neoadjuvant chemotherapy for non-small cell lung cancer.
Semin.Oncol. 26[3 Suppl 10], 25-28. 1999.
152. McCarthy, E. P., Phillips, R. S., Zhong, Z., Drews, R. E., and Lynn, J.
Dying with cancer: patients' function, symptoms, and care preferences as death approaches.
J.Am.Geriatr.Soc. 48[5 Suppl], S110-S121. 2000.
153. McLean, A. N., Semple, P. A., Franklin, D. H., Petrie, G., Millar, E. A., and Douglas, J. G.
The Scottish multi-centre prospective study of bronchoscopy for bronchial carcinoma and suggested audit standards.
Respir.Med. 92[9], 1110-1115. 1998.
154. McLean, A. N., Douglas, J. G., and Semple, P. D.
Scottish national bronchoscopy audit: a prospective multicentre study of 3316 cases against agreed standards. Scottish Thoracic Society.
Respir.Med. 94[5], 511-515. 2000.
155. McWhinney, I. R., Bass, M. J., and Orr, V.
Factors associated with location of death (home or hospital) of patients referred to a palliative care team.
CMAJ. 152[3], 361-367. 1-2-1995.
156. Mercadante, S., Maddaloni, S., Roccella, S., and Salvaggio, L.
Predictive factors in advanced cancer pain treated only by analgesics.
Pain 50[2], 151-155. 1992.
157. Mercadante, S., Armata, M., and Salvaggio, L.
Pain characteristics of advanced lung cancer patients referred to a palliative care service.
Pain 59[1], 141-145. 1994.
158. Miaskowski, C., Nichols, R., Brody, R., and Synold, T.
Assessment of patient satisfaction utilizing the American Pain Society's Quality Assurance Standards on acute and cancer-related pain.
J.Pain Symptom.Manage. 9[1], 5-11. 1994.
159. Miller, A. A., Herndon, J. E., Hollis, D. R., Ellerton, J., Langleben, A., Richards, F., and Green, M. R.
Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: a randomized phase III study of the Cancer and Leukemia Group B.
J.Clin.Oncol. 13[8], 1871-1879. 1995.
160. Monson, J. M., Stark, P., Reilly, J. J., Sugarbaker, D. J., Strauss, G. M., Swanson, S. J., DeCamp, M. M., Mentzer, S. J., and Baldini, E. H.
Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma.
Cancer 82[5], 842-850. 1-3-1998.
161. Montazeri, A., Milroy, R., Gillis, C. R., and McEwen, J.
Interviewing cancer patients in a research setting: the role of effective communication.
Support.Care Cancer 4[6], 447-454. 1996.
162. Montazeri, A., Milroy, R., Hole, D., McEwen, J., and Gillis, C. R.
Quality of life in lung cancer patients. As an important prognostic factor.
Lung Cancer 31[2-3], 233-240. 2001.
163. Mor, V., Masterson-Allen, S., Goldberg, R., Guadagnoli, E., and Wool, M. S.
Pre-diagnostic symptom recognition and help seeking among cancer patients.
J.Community Health 15[4], 253-266. 1990.
164. Motta, G. and Ratto, G. B.
Complications of surgery in the treatment of lung cancer: their relationship with the extent of resection and preoperative respiratory function tests.
Acta Chir Belg. 89[3], 161-165. 1989.
165. Mountain, C. F. and Dresler, C. M.
Regional lymph node classification for lung cancer staging.
Chest 111[6], 1718-1723. 1997.
166. Mountain, C. F.
Revisions in the International System for Staging Lung Cancer.
Chest 111[6], 1710-1717. 1997.
167. Mountain, C. F.
The international system for staging lung cancer.
Semin.Surg.Oncol. 18[2], 106-115. 2000.
168. Muers, M. F. and Round, C. E.
Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organisation Thoracic Group.
Thorax 48[4], 339-343. 1993.
169. Naruke, T., Tsuchiya, R., Kondo, H., Asamura, H., and Nakayama, H.
Implications of staging in lung cancer.
Chest 112[4 Suppl], 242S-248S. 1997.
170. Newaishy, G. A. and Kelly, C. G.
An audit of survival in small cell lung cancer.
Clin.Oncol.R.Coll.Radiol. 4[6], 362-367. 1992.
171. Okada, M., Yoshikawa, K., Hatta, T., and Tsubota, N.
Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller?
Ann.Thorac.Surg. 71[3], 956-960. 2001.
172. Okawara, G., Rusthoven, J., Newman, T., Findlay, B., and Evans, W.
Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
Cancer Prev.Control 1[3], 249-259. 1997.
173. Paesmans, M., Sculier, J. P., Lecomte, J., Thiriaux, J., Libert, P., Sergysels, R., Bureau, G., Dabouis, G., Van Cutsem, O., Mommen, P., Ninane, V., and Klastersky, J.
Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years.
Cancer 89[3], 523-533. 1-8-2000.
174. Page, A., Nakhle, G., Mercier, C., Verdant, A., Page, P., Dontigny, L., Allard, S., Gauthier, J. J., and Cossette, R.
Surgical treatment of bronchogenic carcinoma: the importance of staging in evaluating late survival.
Can.J.Surg. 30[2], 96-99. 1987.
175. Palazzi, M., Villa, S., Leonardi, M. C., and Milani, F.
Indications, results and techniques of radiotherapy in the treatment of small-cell lung cancer.
Tumori 82[4], 345-352. 1996.
176. Parquin, F., Marchal, M., Mehiri, S., Herve, P., and Lescot, B.
Post-pneumonectomy pulmonary edema: analysis and risk factors.
Eur.J.Cardiothorac.Surg. 10[11], 929-932. 1996.
177. Patel, R. L., Townsend, E. R., and Fountain, S. W.
Elective pneumonectomy: factors associated with morbidity and operative mortality.
Ann.Thorac.Surg. 54[1], 84-88. 1992.
178. Pater, J. L., Zee, B., Palmer, M., Johnston, D., and Osoba, D.
Fatigue in patients with cancer: results with National Cancer Institute of Canada Clinical Trials Group studies employing the EORTC QLQ-C30.
Support.Care Cancer 5[5], 410-413. 1997.
179. Patz, E. F., Rossi, S., Harpole, D. H., Herndon, J. E., and Goodman, P. C.
Correlation of tumor size and survival in patients with stage IA non-small cell lung cancer.
Chest 117[6], 1568-1571. 2000.
180. Pignon, J. P., Arriagada, R., Ihde, D. C., Johnson, D. H., Perry, M. C., Souhami, R. L., Brodin, O., Joss, R. A., Kies, M. S., Lebeau, B., and et, al.
A meta-analysis of thoracic radiotherapy for small-cell lung cancer [see comments].
N.Engl.J.Med. 327[23], 1618-1624. 3-12-1992.
181. Pignon, T., Gregor, A., Schaake, Koning C., Roussel, A., Van Glabbeke, M., and Scalliet, P.
Age has no impact on acute and late toxicity of curative thoracic radiotherapy.
Radiother.Oncol. 46[3], 239-248. 1998.
182. Porta, M., Gallen, M., Malats, N., and Planas, J.
Influence of "diagnostic delay" upon cancer survival: an analysis of five tumour sites.
J.Epidemiol.Community Health 45[3], 225-230. 1991.
183. Porte, H., Siat, J., Guibert, B., Lepimpec-Barthes, F., Jancovici, R., Bernard, A., Foucart, A., and Wurtz, A.
Resection of adrenal metastases from non-small cell lung cancer: a multicenter study.
Ann.Thorac.Surg. 71[3], 981-985. 2001.
184. Portenoy, R. K., Miransky, J., Thaler, H. T., Hornung, J., Bianchi, C., Cibas-Kong, I., Feldhamer, E., Lewis, F., Matamoros, I., Sugar, M. Z., and .
Pain in ambulatory patients with lung or colon cancer. Prevalence, characteristics, and effect.
Cancer 70[6], 1616-1624. 15-9-1992.
185. Prescott, E., Osler, M., Andersen, P. K., Hein, H. O., Borch, Johnsen K., Lange, P., Schnohr, P., and Vestbo, J.
Mortality in women and men in relation to smoking.
Int.J.Epidemiol. 27[1], 27-32. 1998.
186. Radford, J. A., Ryder, W. D., Dodwell, D., Anderson, H., and Thatcher, N.
Predicting septic complications of chemotherapy: an analysis of 382 patients treated for small cell lung cancer without dose reduction after major sepsis.
Eur.J.Cancer 29A[1], 81-86. 1992.
187. Recine, D., Rowland, K., Reddy, S., Lee, M. S., Bonomi, P., Taylor, S., Faber, L. P., Warren, W., Kittle, C. F., and Hendrickson, F. R.
Combined modality therapy for locally advanced non-small cell lung carcinoma.
Cancer 66[11], 2270-2278. 1-12-1990.
188. Reif, M. S., Socinski, M. A., and Rivera, M. P.
Evidence-based medicine in the treatment of non-small-cell lung cancer.
Clin.Chest Med. 21[1], 107-20, ix. 2000.
189. Rens MTM van, Rivière AB de la, and et al.
Prognostic assessment of 2.361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II and IIIA
82.
Chest 2000 117, 374-379. 2001.
190. Rice, T. W., Adelstein, D. J., Koka, A., Tefft, M., Kirby, T. J., Van Kirk, M. A., Taylor, M. E., Olencki, T. E., Peereboom, D., and Budd, G. T.
Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancer.
Ann.Thorac.Surg. 60[3], 586-591. 1995.
191. Ringbaek, T., Borgeskov, S., Lange, P., and Viskum, K.
Diagnostic and therapeutic process and prognosis in suspected lung cancer.
Scand.Cardiovasc.J. 33[6], 337-343. 1999.
192. Ringbaek, T. J., Borgeskov, S., Lange, P., and Viskum, K.
[Therapeutic and prognostic course in patients with suspected lung cancer. Results of combined thoracic surgery-pulmonary medicine evaluation].
Ugeskr.Laeger 160[2], 170-175. 5-1-1998.
193. Robnett, T. J., Machtay, M., Vines, E. F., McKenna, M. G., Algazy, K. M., and McKenna, W. G.
Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer.
Int.J.Radiat.Oncol.Biol.Phys. 48[1], 89-94. 1-8-2000.
194. Rose, J. H., O'Toole, E. E., Dawson, N. V., Thomas, C., Connors, A. F., Wenger, N. S., Phillips, R. S., Hamel, M. B., Cohen, H. J., and Lynn, J.
Age differences in care practices and outcomes for hospitalized patients with cancer.
J.Am.Geriatr.Soc. 48[5 Suppl], S25-S32. 2000.
195. Rose, J. H., O'Toole, E. E., Dawson, N. V., Thomas, C., Connors, A. F., Wenger, N., Phillips, R. S., Hamel, M. B., Reding, D. T., Cohen, H. J., and Lynn, J.
Generalists and oncologists show similar care practices and outcomes for hospitalized late-stage cancer patients. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks for Treatment.
Med.Care 38[11], 1103-1118. 2000.
196. Sagman, U., Maki, E., Evans, W. K., Warr, D., Shepherd, F. A., Sculier, J. P., Haddad, R., Payne, D., Pringle, J. F., and Yeoh, J. L.
Small-cell carcinoma of the lung: derivation of a prognostic staging system.
J.Clin.Oncol. 9[9], 1639-1649. 1991.
197. Sandler, A. B.
Current management of small cell lung cancer.
Semin.Oncol. 24[4], 463-476. 1997.
198. Sandler, A. B., Nemunaitis, J., Denham, C., von Pawel, J., Cormier, Y., Gatzemeier, U., Mattson, K., Manegold, C., Palmer, M. C., Gregor, A., Nguyen, B., Niyikiza, C., and Einhorn, L. H.
Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer.
J.Clin.Oncol. 18[1], 122-130. 2000.
199. Saunders, M., Dische, S., Barrett, A., Harvey, A., Gibson, D., and Parmar, M.
Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee [see comments].
Lancet 350[9072], 161-165. 19-7-1997.
200. Sawyer, T. E., Bonner, J. A., Gould, P. M., Foote, R. L., Deschamps, C., Trastek, V. F., Pairolero, P. C., Allen, M. S., Lange, C. M., and Li, H.
Effectiveness of postoperative irradiation in stage IIIA non-small cell lung cancer according to regression tree analyses of recurrence risks.
Ann.Thorac.Surg. 64[5], 1402-1407. 1997.
201. Sessa, C., Roggero, E., Pampallona, S., Regazzoni, S., Ghielmini, M., Lang, M., Marx, B., Neuenschwander, H., Pagani, O., Vasilievic, V., and Cavalli, F.
The last 3 months of life of cancer patients: medical aspects and role of home-care services in southern Switzerland [see comments].
Support.Care Cancer 4[3], 180-185. 1996.
202. Shah, R., Sabanathan, S., Richardson, J., Mearns, A. J., and Goulden, C.
Results of surgical treatment of stage I and II lung cancer.
J.Cardiovasc.Surg.Torino 37[2], 169-172. 1996.
203. Shepherd, F. A.
The role of chemotherapy in the treatment of small cell lung cancer.
Chest Surg.Clin.N.Am. 7[1], 113-133. 1997.
204. Silvestri, G., Pritchard, R., and Welch, H. G.
Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews.
BMJ 317[7161], 771-775. 19-9-1998.
205. Simpson, J. R., Bauer, M., Wasserman, T. H., Perez, C. A., Emami, B., Wiegensberg, I., Zinninger, M., and Durbin, L. M.
Large fraction irradiation with or without misonidazole in advanced non-oat cell carcinoma of the lung: a phase III randomized trial of the RTOG. Radiation Therapy Oncology Group.
Int.J.Radiat.Oncol.Biol.Phys. 13[6], 861-867. 1987.
206. Sitzia, J. and Wood, N.
Patient satisfaction with cancer chemotherapy nursing: a review of the literature.
Int.J.Nurs.Stud. 35[1-2], 1-12. 1998.
207. Smeenk, F. W., van Haastregt, J. C., de Witte, L. P., and Crebolder, H. F.
Effectiveness of home care programmes for patients with incurable cancer on their quality of life and time spent in hospital: systematic review.
BMJ 316[7149], 1939-1944. 27-6-1998.
208. Sorensen, J. B., Badsberg, J. H., and Olsen, J.
Prognostic factors in inoperable adenocarcinoma of the lung: a multivariate regression analysis of 259 patients.
Cancer Res. 49[20], 5748-5754. 15-10-1989.
209. Souquet, P. J., Chauvin, F., Boissel, J. P., Cellerino, R., Cormier, Y., Ganz, P. A., Kaasa, S., Pater, J. L., Quoix, E., and Rapp, E.
Polychemotherapy in advanced non small cell lung cancer: a meta-analysis [see comments].
Lancet 342[8862], 19-21. 3-7-1993.
210. Sridhar, K. S., Raub, W., Duncan, R. C., Hilsenbeck, S., and Richman, S. P.
Lung carcinoma in 1,336 patients
164.
Am.J.Clin.Oncol. 14[6], 496-508. 1991.
211. Steinbaum, S. S., Uretzky, I. D., McAdams, H. P., Torrington, K. G., and Cohen, A. J.
Exploratory thoracotomy for nonresectable lung cancer.
Chest 107[4], 1058-1061. 1995.
212. Stephens, R. J., Girling, D. J., Bleehen, N. M., Moghissi, K., Yosef, H. M., and Machin, D.
The role of post-operative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Medical Research Council Lung Cancer Working Party.
Br.J.Cancer 74[4], 632-639. 1996.
213. Storm, H. H., Dickman, P. W., Engeland, A., Haldorsen, T., and Hakulinen, T.
Do morphology and stage explain the inferior lung cancer survival in Denmark?
Eur.Respir.J. 13[2], 430-435. 1999.
214. Sugiura, S., Ando, Y., Minami, H., Ando, M., Sakai, S., and Shimokata, K.
Prognostic value of pleural effusion in patients with non-small cell lung cancer.
Clin.Cancer Res. 3[1], 47-50. 1997.
215. Suzuki, K., Nagai, K., Yoshida, J., Nishimura, M., Takahashi, K., Yokose, T., and Nishiwaki, Y.
Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma. A comparison of prognostic factors for each pathologic TNM stage based on multivariate analyses.
Cancer 86[10], 1976-1984. 15-11-1999.
216. Suzuki, K., Nagai, K., Yoshida, J., Nishimura, M., Takahashi, K., and Nishiwaki, Y.
The prognosis of surgically resected N2 non-small cell lung cancer: the importance of clinical N status.
J.Thorac.Cardiovasc.Surg. 118[1], 145-153. 1999.
217. Suzuki, K., Nagai, K., Yoshida, J., Moriyama, E., Nishimura, M., Takahashi, K., and Nishiwaki, Y.
Prognostic factors in clinical stage I non-small cell lung cancer.
Ann.Thorac.Surg. 67[4], 927-932. 1999.
218. Tamura, M., Ueoka, H., Kiura, K., Tabata, M., Shibayama, T., Miyatake, K., Gemba, K., Hiraki, S., and Harada, M.
Prognostic factors of small-cell lung cancer in Okayama Lung Cancer Study Group Trials [see comments].
Acta Med.Okayama 52[2], 105-111. 1998.
219. Tanaka, F., Yanagihara, K., Otake, Y., Miyahara, R., Kawano, Y., Nakagawa, T., Shoji, T., and Wada, H.
Surgery for non-small cell lung cancer: postoperative survival based on the revised tumor-node-metastasis classification and its time trend.
Eur.J.Cardiothorac.Surg. 18[2], 147-155. 2000.
220. Teo, P., Tai, T. H., Choy, D., and Tsui, K. H.
A randomized study on palliative radiation therapy for inoperable non small cell carcinoma of the lung.
Int.J.Radiat.Oncol.Biol.Phys. 14[5], 867-871. 1988.
221. Thoren-Todoulos, E.
[Psychosocial factors are limiting the possibility of dying at home].
Lakartidningen 96[5], 472-475. 3-2-1999.
222. Urban, T., Chastang, C., Lebas, F. X., Duhamel, J. P., Adam, G., Darse, J., Brechot, J. M., and Lebeau, B.
The addition of cisplatin to cyclophosphamide-doxorubicin-etoposide combination chemotherapy in the treatment of patients with small cell lung carcinoma: A randomized study of 457 patients. "Petites Cellules" Group.
Cancer 86[11], 2238-2245. 1-12-1999.
223. Valente, M., Pastorino, U., Piva, L., Guzzon, A., and Ravasi, G.
Post-thoracotomy diagnostic and staging conversion rates of clinically staged I lung cancer.
Tumori 67[3], 239-243. 1981.
224. van Den Bosch, J. M., Gelissen, H. J., and Wagenaar, S. S.
Exploratory thoracotomy in bronchial carcinoma.
J.Thorac.Cardiovasc.Surg. 85[5], 733-737. 1983.
225. Van Raemdonck DE, Schneider A, and et al.
Surgical treatment for higher stage non-small cell lung cancer.
Ann Thorac surg 1992 54, 999-1013. 2001.
226. van Rens, M. T., de la Riviere, A. B., Elbers, H. R., and van Den Bosch, J. M.
Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA.
Chest 117[2], 374-379. 2000.
227. Vansteenkiste, J., De Leyn, P., Deneffe, G., Menten, J., Lerut, T., and Demedts, M.
Present status of induction treatment in stage IIIA-N2 non-small cell lung cancer: a review. The Leuven Lung Cancer Group.
Eur.J.Cardiothorac.Surg. 13[1], 1-12. 1998.
228. Vansteenkiste, J. F., De Leyn, P. R., Deneffe, G. J., Lerut, T. E., and Demedts, M. G.
systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group [see comments].
[9124], -63. 98.
229. Wada, H., Fukuse, T., and Hitomi, S.
Long-term survival of surgical cases of lung cancer.
Lung Cancer 13[3], 269-274. 1995.
230. Wada, H., Hitomi, S., and Teramatsu, T.
Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery [see comments].
J.Clin.Oncol. 14[4], 1048-1054. 1996.
231. Wada, H., Tanaka, F., Yanagihara, K., Ariyasu, T., Fukuse, T., Yokomise, H., Inui, K., Mizuno, H., Ike, O., and Hitomi, S.
Time trends and survival after operations for primary lung cancer from 1976 through 1990.
J.Thorac.Cardiovasc.Surg. 112[2], 349-355. 1996.
232. Wada, H., Nakamura, T., Nakamoto, K., Maeda, M., and Watanabe, Y.
Thirty-day operative mortality for thoracotomy in lung cancer.
J.Thorac.Cardiovasc.Surg. 115[1], 70-73. 1998.
233. Wahi, R., McMurtrey, M. J., DeCaro, L. F., Mountain, C. F., Ali, M. K., Smith, T. L., and Roth, J. A.
Determinants of perioperative morbidity and mortality after pneumonectomy.
Ann.Thorac.Surg. 48[1], 33-37. 1989.
234. Waller, D. A., Gebitekin, C., Saunders, N. R., and Walker, D. R.
Noncardiogenic pulmonary edema complicating lung resection.
Ann.Thorac.Surg. 55[1], 140-143. 1993.
235. Walsh, G. L., O'Connor, M., Willis, K. M., Milas, M., Wong, R. S., Nesbitt, J. C., Putnam, J. B., Lee, J. J., and Roth, J. A.
Is follow-up of lung cancer patients after resection medically indicated and cost-effective?
Ann.Thorac.Surg. 60[6], 1563-1570. 1995.
236. Watanabe, Y., Murakami, S., Oda, M., Ohta, Y., Watanabe, S., Nozawa, H., Kamesui, T., Nozaki, Y., Nonomura, A., Minato, H., and Kitagawa, M.
Tumor size and extension of lymph node metastases in N2 lung cancer.
Ann.Ital.Chir 70[6], 889-892. 1999.
237. Watson, P. N. and Evans, R. J.
Intractable pain with lung cancer.
Pain 29[2], 163-173. 1987.
238. Wertzel, H., Siebert, H., Lange, W., Swoboda, L., Graf, E., and Hasse, J.
Results after surgery in stage-I bronchogenic carcinoma.
Thorac.Cardiovasc.Surg. 46[6], 365-369. 1998.
239. Wigren, T., Oksanen, H., and Kellokumpu, Lehtinen P.
A practical prognostic index for inoperable non-small-cell lung cancer [see comments].
J.Cancer Res.Clin.Oncol. 123[5], 259-266. 1997.
240. Wingo, P. A., Ries, L. A., Parker, S. L., and Heath-CW, Jr.
Long-term cancer patient survival in the United States [see comments].
Cancer Epidemiol.Biomarkers Prev. 7[4], 271-282. 1998.
241. Wolf, M., Holle, R., Hans, K., Drings, P., and Havemann, K.
Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): the role of sex as a predictor for survival.
Br.J.Cancer 63[6], 986-992. 1991.
242. Work E, Nielsen OS, and et al .
Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer
124.
J Clin Oncol 1997 15, 3030-3037. 2001.
243. Wurschmidt, F., Bunemann, H., Ehnert, M., and Heilmann, H. P.
Is the time interval between surgery and radiotherapy important in operable nonsmall cell lung cancer? A retrospective analysis of 340 cases.
Int.J.Radiat.Oncol.Biol.Phys. 39[3], 553-559. 1-10-1997.
244. Yip, D. and Harper, P. G.
Predictive and prognostic factors in small cell lung cancer: current status.
Lung Cancer 28[3], 173-185. 2000.
245. Zabora, J., BrintzenhofeSzoc, K., Curbow, B., Hooker, C., and Piantadosi, S.
The prevalence of psychological distress by cancer site.
Psychooncology. 10[1], 19-28. 2001.